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Abstract
Although cerebrovascular impairments are believed to contribute to concussion symptoms,
little information exists regarding brain vasomotor control in adolescent concussion,
particularly during changes in arterial blood pressure (ABP). This research tested the
hypothesis that adolescent concussion is marked by impaired dynamic cerebral
autoregulation (dCA). Thirty concussed adolescents and thirty healthy controls completed
two sit-to-stand trials. Cerebral blood flow velocity and ABP were measured continuously.
Cerebrovascular resistance (CVR) was calculated and the rate of drop in CVR relative to the
change in ABP provided the rate of regulation (RoR). The concussed adolescents were
followed through rehabilitation for up to 12-weeks. At the first visit, the concussed
adolescents demonstrated reduced RoR compared with the healthy controls (0.16±0.04 vs.
0.21±0.07 sec-1; P≤0.001). At the concussed adolescents final visit, RoR recovers to levels
seen in the healthy controls (0.21±0.08 vs. 0.21±0.07 sec-1; P=0.93). Concussed adolescents
demonstrate an impairment in dCA that recovers with symptoms.

Keywords
Cerebral autoregulation, rate of regulation, cerebrovascular resistance, concussion,
adolescents, sit-to-stand, transcranial Doppler ultrasound, cerebral blood flow velocity
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Chapter 1

1

Introduction

Concussion is a subset of traumatic brain injuries (TBI) (McCrory et al., 2013) and is a
major concern among pediatric populations (Stewart, Gilliland, & Fraser, 2014). This
subset of injuries is mild in severity (Grady, 2010; Signoretti, Lazzarino, Tavazzi, &
Vagnozzi, 2011) and generally occurs without loss of consciousness (Karlin, 2011;
Stewart et al., 2014). More than 50% of all TBI cases occur in children and adolescents
with concussion being the most predominant (Choe, Babikian, DiFiori, Hovda, & Giza,
2012; Signoretti et al., 2011). Due to ongoing neurological development, concussive
injuries sustained during maturation places children and adolescents at increased risk for
prolonged recovery, persistent symptoms, and long-term difficulties in neurologic
functioning (Choe et al., 2012; Grady, 2010; Karlin, 2011; McCrory et al., 2013;
Pellman, Lovell, Viano, & Casson, 2006; Stewart et al., 2014).
Concussion is a complex process resulting in functional disturbances (McCrory et
al., 2013). However, the underlying neurological and physiological processes that are
affected are not well understood (Signoretti et al., 2011). Furthermore, structural injuries
are not evident making concussions unidentifiable with standard imaging modalities
(McCrory et al., 2013). Therefore, clinical management of concussion currently relies on
subjective measures, largely the self-reporting of symptoms (McCrory et al., 2013), as
objective markers remain elusive. Uncovering objective markers of concussion is
imperative for improving the overall clinical care of concussion, and more importantly
providing information on physiological recovery in turn aiding clinicians’ decisions
regarding readiness to return to activity and sport.
Regulation of cerebral blood flow (CBF) is a complex, integrative process that
works through changes in vasomotor tone (Faraci & Heistad, 1998; Hughson, Edwards,
O’Leary, & Shoemaker, 2001; Ursino & Lodi, 1998; Zauner & Muizelaar, 1997). Given
the homeostatic nature of CBF control, we would expect to see alterations in
cerebrovascular function following trauma to the brain. In fact, changes in
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cerebrovascular function are manifested in a number of pathologies affecting the brain
including stroke (Girouard & Iadecola, 2006; Meyer et al., 1973), Alzheimer’s (Girouard
& Iadecola, 2006; Kalaria, 1996), and moderate to severe head-injury (Bailey et al., 2013;
Czosnyka, Smielewski, Piechnik, Steiner, & Pickard, 2001; Lang et al., 2003; Lee et al.,
2001; M. S. Vavilala et al., 2004). However, while impaired cerebrovascular function is
associated with moderate and severe head injuries, the evidence supporting these changes
in mild TBI and concussion is less clear.
A common approach to evaluating cerebrovascular function is the assessment of
cerebral autoregulation (CA) which regulates CBF in the face of fluctuating cerebral
perfusion pressure (CPP) (N. A. Lassen, 1959). Through vasomotor adjustments, CA is
able to maintain CBF at relatively constant levels within a CPP range of 50-150 mmHg
(N. A. Lassen, 1959). Investigations of CA following head injury have largely focused on
adults suffering from moderate to severe TBI and have found variably impaired CA
(Bailey et al., 2013; Czosnyka et al., 2001; Lang et al., 2003; Lee et al., 2001). Pediatric
populations and patients suffering from concussion have seldom been studied.
Furthermore, the investigations into head-injury have employed static measures of CA
(Czosnyka et al., 2001; Lang et al., 2003). Static CA looks only at the association
between mean CBF and mean arterial blood pressure (ABP) following induced
alterations or spontaneous changes in ABP (R. B. Panerai, 1998). With this approach,
measures are taken in steady-state and the initial period of transition is ignored, when
ABP and CBF are changing dynamically (R. B. Panerai, Dawson, Eames, & Potter, 2001;
Tiecks, Lam, Aaslid, & Newell, 1995). Therefore, static CA provides information on the
absolute change in CBF for a given change in ABP but overlooks the time course of the
autoregulatory response (R. B. Panerai, 1998; R. B. Panerai et al., 2001; Tiecks et al.,
1995). The use of static measures of CA may be one reason why previous investigations
have found variably impaired CA. Homeostatic processes work to maintain a state of
equilibrium and may seem relatively intact at rest and at low levels of stress. A previous
investigation of cerebral hemodynamic function failed to uncover impairments at rest but
deficiencies were witnessed when participants were subjected to hemodynamic stress
(Bailey et al., 2013). Therefore, by challenging the adaptive dynamics of CA we may
expose impaired cerebrovascular function.
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The primary purpose of this investigation was to examine underlying
cerebrovascular outcomes associated with adolescent concussion. More specifically,
application of a dynamic model would allow for the evaluation of dynamic
autoregulatory function. Furthermore, it was of interest to assess the resolution of
dynamic CA throughout clinical recovery. This research tested the hypothesis that
adolescents diagnosed with a concussion would demonstrate impaired dynamic CA when
compared to healthy adolescent controls.
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Chapter 2

2

Literature Review

2.1 Concussion
Concussion is a subset of TBI characterized by low velocity injuries and caused by direct
hits to the head or neck, or by indirect hits to the body where the force is transmitted to
the head (Daneshvar, Nowinski, McKee, & Cantu, 2011; McCrory et al., 2013; Stewart et
al., 2014). Despite the presence of impairments in functional neurological outcomes,
structural injury is not evident following concussion with no abnormalities observed
using standard imaging techniques (McCrory et al., 2013; Stewart et al., 2014). Typically,
concussive injuries result in a rapid onset of symptoms though symptoms can develop
gradually over minutes to hours (Daneshvar et al., 2011; McCrory et al., 2013; Stewart et
al., 2014). Symptoms of concussion are widespread but can generally be grouped into
clinical symptoms (i.e. headache, dizziness), physical signs (amnesia, loss of
consciousness), behavioral changes (irritability, emotional), cognitive impairment
(slowed reaction time), and sleep disturbances (Daneshvar et al., 2011; McCrory et al.,
2013; Stewart et al., 2014). Generally, symptoms resolve spontaneously with the majority
of individuals experiencing symptom resolution within 7-10 days (Daneshvar et al., 2011;
McCrory et al., 2013; Stewart et al., 2014). However, in 10-15% of cases symptoms
persist beyond this recovery period and may progress to Post-Concussion Syndrome
(PCS) (McCrory et al., 2013). The definition of PCS varies largely though it has been
recognized when symptoms persist beyond 42 days or 6 weeks (Willer & Leddy, 2006).
The ability to define who will progress to PCS represents a key effort in concussion
research; however, no markers of this progression are currently understood.

2.1.1

Pediatric Concussion

Concussion is a major concern among pediatric populations (Stewart et al., 2014). More
than 50% of all TBI cases occur in children and adolescents with concussion being the
most predominant form of injury (Choe et al., 2012; Signoretti et al., 2011; Stewart et al.,
2014). A large contributor to the high incidence of concussion in youth is their
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involvement in sports and recreational activities (Choe et al., 2012; Daneshvar et al.,
2011; Grady, 2010; Karlin, 2011). In fact, sports- and recreation-related injuries are the
most common mechanism for concussion in this population (Choe et al., 2012;
Daneshvar et al., 2011; Grady, 2010; Karlin, 2011; Stewart et al., 2014). It has been
suggested that child and adolescent brains may be more vulnerable to the functional
outcomes of concussion (Karlin, 2011; Stewart et al., 2014). The reason for such
vulnerability may be related to ongoing neurologic development at this age, placing
children and adolescents at increased risk for prolonged recovery, persistent symptoms,
and long-term impairments in neurologic functioning (Karlin, 2011; Stewart et al., 2014).
Recovery in pediatric populations tends to be prolonged beyond the 7-10-day period
typically seen in adult populations (Field, Collins, Lovell, & Maroon, 2003; Lovell et al.,
2003; McCrory et al., 2013; Pellman et al., 2006). However, investigations have not yet
reported a general timeline for symptom resolution in this population.
Following concussion, a period of cognitive and physical rest is prescribed in the
initial stages of recovery and this period can often become prolonged in pediatric
populations (McCrory et al., 2013; Purcell, 2014; Stewart et al., 2014). Once symptoms
begin to improve, light cognitive activities are progressively introduced and, once
tolerated, pediatric patients can begin modified school attendance (Purcell, 2014). Once
patients are back to full attendance at school, light physical activity can be introduced
(McCrory et al., 2013; Purcell, 2014). Persistent symptoms in the initial stages of
rehabilitation often prolongs the period of rest in pediatric populations and this can be
associated with negative impacts on their emotional and cognitive development (Stewart
et al., 2014). With prolonged absence from school and physical activity, children and
adolescents may experience social withdrawal, high levels of anxiety, irritability, and
depression (Stewart et al., 2014). Furthermore, extended absenteeism from school and
persistent difficulties with memory and concentration can negatively influence
intellectual development (Stewart et al., 2014). Together, this demonstrates the
importance of appropriate rehabilitation of pediatric concussions and the need for a
collaborative approach to ensure optimal care (Purcell, 2014).
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2.1.2

Pathophysiology of Concussion

Despite considerable efforts, many gaps remain in our knowledge of the pathophysiology
of concussion (Signoretti et al., 2011). Much of the research in this area has relied on
animal models of TBI which are accompanied by concerns with the applicability of these
models to injury constructs in humans (Bazarian, Blyth, & Cimpello, 2006; Grady, 2010).
The large majority of TBI research has applied four injury models to rodents including
fluid percussion injuries, controlled cortical impact injuries, weight drop-impact
acceleration injuries, and blast injuries (Xiong, Mahmood, & Chopp, 2013). With fluid
percussion injuries, the severity of the injury depends on the strength of the pressure
wave created in the fluid and transferred to the intact dura exposed through craniotomy
(Xiong et al., 2013). With this model, there is little control over the biomechanical forces
applied and fluid percussion injuries often induce intracranial hemorrhage, encephalitis,
cortical contusions, and a progressive damage to the grey matter (Xiong et al., 2013)
which are associated with more severe forms of TBI in humans. Controlled cortical
impact injuries applies controlled impacts to the exposed, intact dura and can model a
range a TBI severities through greater control of the biomechanical forces (Xiong et al.,
2013). However, the damage reported with controlled cortical impact injuries are
generally widespread and can involve tissue degeneration (Xiong et al., 2013).
Furthermore, cognitive and emotional deficits associated with controlled cortical impact
injuries can last a year following the injury (Xiong et al., 2013). This injury model may
also be more applicable to moderate or severe forms of head-injury. Similar paradigms
are seen with the weight-drop acceleration model where weight is dropped on the
unprotected skull or the exposed dura (Xiong et al., 2013). This model commonly
produces cortical contusions and hemorrhages (Xiong et al., 2013) and may relate to
more severe forms of TBI. Considerations must also be made for the physiological
differences between the rodent species and humans. Nonetheless, animal models have
provided a groundwork for our understanding of the pathophysiology of TBI. Some
human evidence has supported the occurrence of similar mechanical and metabolic
changes following head injury (Bazarian et al., 2006; Choe et al., 2012; Grady, 2010;
Willer & Leddy, 2006).
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Functional neurological outcomes and concussion symptoms may relate to
physical damage to nerves (Bazarian et al., 2006). Diffuse axonal injuries refers to the
stretching of axons following shear, compression, or torsional forces to neural tissue
(Bazarian et al., 2006; Grady, 2010; Willer & Leddy, 2006). With diffuse axonal injuries,
changes in the arrangement of cytoskeletal elements of the axons are observed (Bazarian
et al., 2006; Choe et al., 2012). In particular, axonal neurofilaments and microtubules
become damaged which disrupts axonal transport (Bazarian et al., 2006; Choe et al.,
2012). Shortly after the injury axonal swelling is detected and an accumulation of
proteins, in particular the amyloid precursor protein, is noted at the site of injury
(Bazarian et al., 2006; Choe et al., 2012; Grady, 2010). This protein is common in
identifying areas of injury in autopsies and experimental models of TBI in rodents
(Bazarian et al., 2006; Ciallella et al., 2002; Itoh et al., 2009).
Metabolism within nerves may also affect their function, producing neurologic
symptoms. The metabolic changes that occur following TBI are often referred to as a
complex, metabolic cascade (Signoretti et al., 2011; Willer & Leddy, 2006). Initial
depolarization of neuronal membranes results in the release of several neurotransmitters,
specifically excitatory amino acids (Grady, 2010; Signoretti et al., 2011; Willer & Leddy,
2006). Particularly, there is a considerable increase in the concentration of glutamate
(Choe et al., 2012). The release of these neurotransmitters creates fluxes of potassium,
sodium, and calcium across neuronal and vascular membranes (Choe et al., 2012; Grady,
2010; Willer & Leddy, 2006). The cells attempt to regain equilibrium, in turn, leading to
a surge in glucose utilization (Willer & Leddy, 2006). However, influx of calcium into
vascular smooth muscle leads to vasoconstriction thereby reducing CBF and glucose
delivery (Grady, 2010; Willer & Leddy, 2006). What follows is a state of metabolic
depression where there is a mismatch between the energy demand of the brain and the
energy supply to the brain (Grady, 2010; Willer & Leddy, 2006). In this hypothesis,
reactive changes in CBF become part of the problem.
Previous investigations have provided evidence of alterations in CBF following
TBI. Largely, a reduction in CBF has been reported in severely head-injured patients
(Adelson et al., 1997; Muizelaar et al., 1989; Obrist, Langfitt, Jaggi, Cruz, & Gennarelli,
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1984). However, one previous investigation has also demonstrated a reduction in CBF
following concussion in children and adolescents aged 11 to 15 years (Maugans, Farley,
Altaye, Leach, & Cecil, 2012). In contrast, another investigation provided support for
normal or below normal CBF values immediately following severe head injury that was
followed by a period of hyperemia lasting between 1 and 14 days before returning to
normal or below normal values (Overgaard & Tweed, 1974). Therefore, a state of
reduced CBF appears to develop following head-injury of varying severities though the
time course of these changes has not been elucidated. Given the state of increased energy
demand, reduced CBF would have serious implications on cerebral perfusion (Grady,
2010; Willer & Leddy, 2006). Therefore, understanding alterations in CBF following
concussion becomes an important piece of information in guiding concussion
management (Grady, 2010).

2.2 Cerebral Blood Flow
Blood flow in the cerebral vasculature differs from systemic circulation largely due to the
encompassment of the cerebral circulatory system in the skull (Czosnyka & Pickard,
2004; Czosnyka et al., 2001; Ursino & Lodi, 1998). With the cerebral vasculature
enclosed in the skull, the vessels are naturally exposed to the influence of external
sources of pressure termed intracranial pressure (ICP) (Czosnyka & Pickard, 2004;
Ursino & Lodi, 1998). The main determinants of CBF are CPP and cerebral vascular
resistance (CVR), with CPP determined as mean arterial pressure (MAP) minus ICP
(Zauner & Muizelaar, 1997). Therefore, CBF is defined as CPP/CVR (Zauner &
Muizelaar, 1997). Because the cerebral circulation is enclosed in the skull it is difficult to
make direct measures of CBF in humans and research has largely relied on indirect
measurements.

2.2.1

Methods of Measuring Cerebral Blood Flow

The first measurement of CBF came in 1945 when Kety and Schmidt applied the inert
gas method to animals and humans. The method was based on the principles that i) the
rate of gas uptake by the brain depends on the rate of blood flow to the brain and ii) the
arterio-venous gas difference depends on the volume of blood flowing to the brain (Kety
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& Schmidt, 1945). More specifically, the inert gas method often references the Fick
equation which, when applied to a single organ, describes CBF as the ratio of the rate of
gas uptake relative to the arterio-venous gas difference (Kety & Schmidt, 1945; N. A.
Lassen, 1959). Following inhalation of an inert gas, blood samples are taken from a
peripheral artery and the internal jugular vein (N. A. Lassen, 1959). Blood samples from
a peripheral artery, such as the femoral artery utilized in the original work by Kety and
Schmidt (1945), are believed to be a good representation of blood in the cerebral arteries
(N. A. Lassen, 1959). The venous concentration of gas provides a measure of the rate of
gas uptake per unit weight of the brain (N. A. Lassen, 1959). An estimation of total brain
weight is required to provide a value of absolute cerebral blood flow (R. B. Panerai,
1998). Although the inert gas method relies on a number of assumptions, good agreement
has been demonstrated between this method and direct measures of cerebral blood flow
in monkeys (N. A. Lassen, 1959). However, jugular venous samples are difficult to
perform in humans and are more invasive.
The inert gas method was further developed and the xenon clearance technique
was first described in 1963 by Lassen and colleagues (Obrist, Thompson, King, & Wang,
1967). With this approach, an inert, diffusible radioisotope is injected into one of the
internal carotid arteries (ICA) and monitored extra-cranially through gamma
spectroscopy for 45 to 60 minutes (Obrist et al., 1967). The resulting clearance curves are
subjected to a two-compartment analysis which provides separate blood flow for grey and
white matter (Ingvar, Cronqvist, Ekberg, Risberg, & Høedt-Rasmussen, 1965; Obrist et
al., 1967). This approach involves intra-ICA injections in addition to jugular venous
sampling making this method invasive.
In addition, another method for the indirect measurement of CBF was introduced
in 1947 (Gibbs, Maxwell, & Gibbs, 1947). Gibbs and colleagues (1947) developed the
indicator injection method based on the Stewart Hamilton techniques for measuring flow
(N. A. Lassen, 1959). A biologically inert indicator is injected into one of the ICA (N. A.
Lassen, 1959). The concentration of the indicator subsequently measured in jugular
venous samples is related to the rate of flow in the brain (Nylin & Blömer, 1955). Again,
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this method involves intra-ICA injections and jugular venous samples making it a more
invasive procedure.
In 1977, near-infrared spectroscopy (NIRS) was described as a non-invasive
means of quantifying CBF (Jobsis, 1977). Near-infrared light is applied to the intact skull
and transmitted through biological tissue (Wyatt et al., 1990). Brain tissue is relatively
transparent in the near-infrared range allowing non-invasive measures of tissue oxygen
saturation (Jobsis, 1977; Murkin & Arango, 2009; Wyatt et al., 1990). Near-infrared light
can be transmitted through tissue up to a distance of 8 cm (Wyatt et al., 1990).
Reflectance-mode NIRS is most commonly employed where receiving sensors are placed
ipsilateral to the transmitter (Wyatt et al., 1990). The Beer-Lambert equation, using the
difference between the intensity of the transmitted light and received light, provides
regional tissue oxygen saturation. Total cerebral hemoglobin subsequently gives an
estimation of blood flow velocity (Wyatt et al., 1990).
Presently, Transcranial Doppler ultrasound (TCD) has become the most prevalent
method of measuring cerebral blood flow in conscious humans due to its ability to
provide continuous information in a non-invasive manner. This method is discussed in
detail below.

2.2.1.1

Transcranial Doppler Ultrasound

Doppler ultrasound was first used to measure blood flow velocity in the extracranial
vessels in 1965 (Miyazaki & Kato, 1965). The technique was available to measure blood
flow velocity in the intracranial vessels as well, though it was limited to use during
surgical procedures due to the thickness of the skull and the subsequent attenuation of the
sound waves (Aaslid, Markwalder, & Nornes, 1982). However, in 1982, Aaslid and
colleagues demonstrated that insonation of the major cerebral arteries was possible within
the frequency range of 1-2 MHz and through the thinner regions of the skull termed
acoustic windows (Aaslid et al., 1982). Four acoustic windows have been identified and
applied in TCD examinations which include the transtemporal, transocular, suboccipital,
and transcondylar windows (Aaslid et al., 1982; R. B. Panerai, 2009; C. Willie et al.,
2011). The transtemporal window is most commonly utilized in TCD examinations as the
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middle cerebral artery (MCA), anterior cerebral artery (ACA), and posterior cerebral
artery (PCA) can be insonated with this approach (R. B. Panerai, 2009; C. Willie et al.,
2011). The MCA, ACA, and PCA are vessels of the circle of Willis, which plays an
important role in absorbing pressure and protecting the cerebral microcirculation
(Vrselja, Brkic, Mrdenovic, Radic, & Curic, 2014). The circle of Willis originates from
two major sources, the vertebral arteries and the internal carotid arteries (Iqbal, 2013;
Vrselja et al., 2014). The vertebral arteries anastomose forming the basilar artery which
in turn branches into the two PCA (Iqbal, 2013; Vrselja et al., 2014). The internal carotid
arteries branch into the MCA, ACA, and the posterior communicating arteries with the
two ACA joined by the anterior communicating artery (Iqbal, 2013; Vrselja et al., 2014).
Together the PCA, posterior communicating arteries, MCA, ACA, and anterior
communicating artery form the circle of Willis (Iqbal, 2013; Vrselja et al., 2014) (Figure
2.1).
Blood flow throughout the major arteries of the circulatory system is believed to be
predominantly laminar leading to a parabolic flow profile, particularly during peak
systole, with the highest velocity in the center of the vessel and the lowest velocities
along the walls of the vessel (R. B. Panerai, 2009; C. Willie et al., 2011). TCD provides
continuous information on these velocity profiles and subsequently calculates a variety of
metrics such as the instantaneous peak velocity and mean velocity profiles. The peak
velocity profiles represent the maximum velocity at any moment in time while the mean
velocity profiles represent the intensity weighted mean of a cross section of the vessel
(Newell, Aaslid, Lam, Mayberg, & Winn, 1994; R. B. Panerai, 2009; C. Willie et al.,
2011). Mean velocity profiles require a high signal-to-noise ratio and slight movements
of the sample volume can lead to inaccurate estimations of flow (Newell et al., 1994). In
contrast, slight movement of the sample volume has little effect on peak velocity profiles
(Newell et al., 1994). Therefore, mean velocity profiles may be more representative of
overall CBF though peak velocity profiles may be more dependable indexes of CBF,
particularly in cases where you cannot visualize the position of the Doppler window
within the artery as is the case with TCD (Newell et al., 1994).
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The Doppler probe emits sound waves that are reflected off the red blood cells
travelling through the insonated artery (R. B. Panerai, 2009; C. Willie et al., 2011). The
reflected sound waves are detected by the probe and the shift in frequency between the
transmitted and reflected waves corresponds to the blood flow velocity (C. Willie et al.,
2011). Changes in cerebral blood flow velocity (CBFV) are proportional to changes in
CBF provided the cross-sectional area (CSA) of the insonated vessel remains constant
(Aaslid, Lindegaard, Sorteberg, & Nornes, 1989; Clark et al., 1996; Giller, Bowman,
Dyer, Mootz, & Krippner, 1993; R. B. Panerai, 1998; Serrador, Picot, Rutt, Shoemaker,
& Bondar, 2000; C. Willie et al., 2011). Whether the larger basal arteries of the brain
undergo diameter changes with alterations in ABP and end tidal carbon dioxide partial
pressure (PETCO2) has been studied extensively. However, the results of the
investigations remain equivocal, with some studies arguing no change in vessel diameter
(Aaslid et al., 1989; Aaslid, Newell, Stooss, Sorteberg, & Lindegaard, 1991; Bishop,
Powell, & Rutt, 1986; Giller et al., 1993; Larsen, Olsen, Hansen, Paulson, & Knudsen,
1994; Lindegaard et al., 1987; Newell et al., 1994; Serrador et al., 2000; Sorteberg et al.,
1989; Ter Minassian et al., 1998; Valdueza et al., 1997) and other studies providing
evidence of diameter changes (Coverdale, Gati, Opalevych, Perrotta, & Shoemaker,
2014; Dahl, Russell, Nyberg-Hansen, & Rootwelt, 1989; Faraci & Heistad, 1990; Madsen
et al., 1993).
The CSA of the insonated artery has been shown to remain unaltered, at least in a
statistical sense, with modest variations in both ABP and PETCO2 (Bishop et al., 1986;
Giller et al., 1993; Larsen et al., 1994; Lindegaard et al., 1987; Serrador et al., 2000;
Valdueza et al., 1997). Following alterations in ABP via drug-infusion, measures of
CBFV with TCD and CBF with xenon clearance techniques or electromagnetic
flowmeters were collected (Larsen et al., 1994; Lindegaard et al., 1987). The measures of
CBFV and CBF were highly correlated suggesting a constant vessel diameter (Larsen et
al., 1994; Lindegaard et al., 1987). Similarly, following alterations in PETCO2 via the
administration of a 5% carbon dioxide (CO2) gas mixture, CBFV and CBF as measured
with TCD and xenon clearance techniques, respectively, were strongly correlated (Bishop
et al., 1986). Furthermore, a small number of studies have employed magnetic resonance
imaging (MRI) to measure vessel diameter (Serrador et al., 2000; Valdueza et al., 1997).
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Serrador and colleagues (2000) employed lower-body negative pressure (LBNP) to
produce changes in ABP and, in separate conditions, altered PETCO2 with the
administration of a CO2 gas mixture and induced hyperventilation. Vessel CSA remained
statistically similar under all conditions (Serrador et al., 2000). Valdueza and colleagues
(1997) also produced alterations in PETCO2 via induced hyperventilation and similarly
found no change in vessel CSA. One investigation used craniotomy procedures to make
direct measures of MCA CSA (Giller et al., 1993). With the infusion of nitroprusside,
ABP dropped 30 ± 16 mmHg and a 2.5% change in MCA CSA was observed (Giller et
al., 1993). Although a small change was witnessed, it has been argued that this change in
CSA was not significant enough to result in differences between CBFV and CBF
measures (Giller et al., 1993; Newell et al., 1994).
Despite strong evidence supporting constant vessel diameter, other investigations
have reported changes in vessel CSA with alterations in ABP or PETCO2 (Coverdale et
al., 2014; Dahl et al., 1989; Faraci & Heistad, 1990; Madsen et al., 1993). In fact, when
similar techniques were employed to measure CBFV and CBF, disparities were witnessed
between the measures suggesting a change in the CSA of the vessel (Dahl et al., 1989).
Following the administration of nitroglycerin, CBFV, measured with TCD, decreased
(Dahl et al., 1989). However, no significant changes were observed in CBF measured
with xenon clearance and single-photon emission computed tomography (Dahl et al.,
1989). Therefore, conduit vessel CSA must have increased to maintain CBF. In addition,
a recent MRI study measured vessel CSA following alterations in PETCO2 (Coverdale et
al., 2014). An increase in PETCO2 of approximately 10 mmHg from normocapnia
resulted in an increase in MCA CSA of 0.9 mm2 (Coverdale et al., 2014). During a
decrease in PETCO2 of 13 mmHg from normocapnia, the MCA CSA decreased by 0.5
mm2 (Coverdale et al., 2014).
The discrepancies between investigations is likely due to the methodological
techniques employed and the magnitude of stimuli induced. For instance, the MRI studies
that reported no change in MCA CSA were performed at 1.5 Tesla (Serrador et al., 2000;
Valdueza et al., 1997) while the more recent MRI study demonstrating changes in MCA
CSA used 3 Tesla strength with greater spatial resolution (Coverdale et al., 2014).
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Furthermore, the changes in ABP between investigations ranged from 2-30 mmHg and
the changes in PETCO2 between investigations ranged from 8-13 mmHg. Therefore,
future investigations must consider the level of stimulus and methodological techniques
in the experimental design to minimize the potential of vessel CSA changes.

Figure 2.1: The arteries at the base of the brain. The arterial anastomoses were
described in detail by Thomas Willis and are commonly referred to as the circle of
Willis. Reproduction of a lithograph plate from Gray’s Anatomy from the 20th
U.S. edition of Gray’s Anatomy of the Human Body, originally published in 1918.

2.3 Cerebral Blood Flow Regulation
The brain has a high metabolic demand (Van Beek, Claassen, Rikkert, & Jansen, 2008;
C. K. Willie, Tzeng, Fisher, & Ainslie, 2014), receiving approximately 15% of total
cardiac output and accounting for roughly 20% of overall oxygen consumption (Jain,
Langham, & Wehrli, 2010; Y.-C. Tzeng & Ainslie, 2014; Udomphorn, Armstead, &
Vavilala, 2008). In addition, the brain has a limited capacity for storage of substrates
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(Y.-C. Tzeng & Ainslie, 2014). Together, this creates a need for the precise regulation of
CBF leading to complex and integrative mechanisms of control (Udomphorn et al., 2008;
C. K. Willie et al., 2014). To sustain appropriate levels of brain perfusion, CBF is tightly
regulated by the partial pressure of arterial carbon dioxide (PaCO2), cerebral metabolism,
the autonomic nervous system (ANS), and ABP (C. K. Willie et al., 2014). These
contributors are discussed in detail below.

2.3.1

Carbon Dioxide

The cerebral vasculature has a high sensitivity to PaCO2 that is unique to the cerebral
circulation (Brugniaux, Hodges, Hanly, & Poulin, 2007; Ursino & Lodi, 1998). An
increase in PaCO2 leads to dilation of the cerebral vasculature and an increase in CBF,
while a decrease in PaCO2 leads to vasoconstriction and a decrease in CBF (Brugniaux et
al., 2007). With each mmHg increase in PaCO2, CBF generally increases 3-4% reaching
peak flow approximately 10-20 mmHg above normocapnia (Brugniaux et al., 2007).
With decreases in PaCO2, CBF is generally decreased 2-3% per mmHg to a minimum
level that is reached within the range of 10-15 mmHg (Brugniaux et al., 2007).
It is quite clear that alterations in PaCO2 are accompanied by changes in CBF
(Brugniaux et al., 2007; Ursino & Lodi, 1998). However, for some time, it was unknown
if the CBF response was a result of PaCO2 itself, or possibly changes in pH that
accompany the changes in PaCO2 (C. K. Willie et al., 2014). Under conditions where
PaCO2 was maintained and blood pH was altered, CBF was not influenced in animals
(Harper & Bell, 1963) or in humans (Lambertsen, Semple, Smyth, & Gelfand, 1961).
However, changes in vasomotor tone were witnessed when extravascular pH was altered
in animal experiments (Kontos, Raper, & Patterson, 1977; Kontos, Wei, Raper, &
Patterson, 1977; Wahl, Deetjen, Thurau, Ingvar, & Lassen, 1970). These observations led
to the understanding that CO2 molecules diffuse across the blood-brain barrier leading to
alterations in extravascular pH and consequently influencing vasomotor tone
(Lambertsen et al., 1961; N. Lassen, 1968). Animal studies (Apkon, Weed, & Boron,
1997; Koehler & Traystman, 1982; Kontos, Raper, et al., 1977; Kontos, Wei, et al., 1977;
Peng, Ivarsen, Nilsson, & Aalkjær, 1998; Wahl et al., 1970) and in vivo vascular
preparations (Dabertrand, Nelson, & Brayden, 2012) have provided further evidence
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supporting this view. Therefore, the CBF response appears to result from an interaction
between PaCO2 and pH.
What remains unclear are the mechanisms that alter vasomotor tone in response to
changes in PaCO2 and extravascular pH. Potassium (K+) channels are suggested to play a
role in the PaCO2 and extravascular pH effect on vasomotor tone. Several K+ channels
have been identified in cerebral blood vessels with four main types being recognized
including calcium-activated K+ channels, delayed rectifier K+ channels, inward rectifier
K+ channels, and ATP-sensitive K+ channels (Kitazono, Faraci, Taguchi, & Heistad,
1995). Specifically, delayed rectifier, calcium-activated, and ATP-sensitive K+ channels
are believed to contribute to hypercapnia-induced vasodilation (Kitazono et al., 1995;
Lindauer, Vogt, Schuh-Hofer, Dreier, & Dirnagl, 2003). Animal research demonstrated
the attenuation of hypercapnia-induced vasodilation following the inhibition of the
calcium-activated K+ channels (Lindauer et al., 2003). Furthermore, a complete
suppression of hypercapnia-induced vasodilation occurred following inhibition of both
the calcium-activated and ATP-sensitive K+ channels (Lindauer et al., 2003).
The potent dilator nitric oxide (NO) is also thought to play a role in the cerebral
vascular response to PaCO2 and extravascular pH. Infusion of a NO donor, sodium
nitroprusside, provoked a reduction in MCA constriction following hypocapnia and an
increase in MCA dilation following hypercapnia (Lavi, Egbarya, Lavi, & Jacob, 2003).
Furthermore, the dilatory response of the MCA to hypercapnia was lower following the
infusion of a NO synthase inhibitor, NG-Monomethyl-L-arginine (L-NMMA), and this
effect was subsequently reversed with the infusion of L-arginine (Schmetterer et al.,
1997). In contrast, Ide et al. (2007) found no difference in the hypercapnia induced
increase in MCA flow velocity with or without the infusion of L-NMMA. This would
suggest that L-NMMA did not attenuate the dilatory effect of NO providing evidence that
NO does not influence the vasomotor response to PaCO2 and extravascular pH (Kojiro
Ide, Worthley, Anderson, & Poulin, 2007). However, changes in flow velocity reflect
downstream events and it may be that the NO effect of PaCO2 only influences large
cerebral arteries. Animal research has further demonstrated a role of NO, specifically
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produced by neuronal NO synthase, in hypercapnia-induced vasodilation (Lindauer et al.,
2001; Wang, Paulson, & Lassen, 1992).
From this evidence, we can conclude that K+ channels and NO are, in some way,
mediators of the PaCO2 and extravascular pH vasomotor effect. However, there are still
many questions that remain unanswered in the control of carbon dioxide on CBF.

2.3.2

Metabolic Control

Neurovascular coupling refers to the robust balance between local blood flow and
cerebral metabolism and was first recognized by Mosso in 1880 (Iadecola, 2004).
Neuronal activity produces local vasodilation and subsequently a functional hyperemic
response (Iadecola, 1993, 2004; Roy & Sherrington, 1890). The tight coupling has been
attributed to the anatomical interactions and complex signaling between the neurons,
astrocytes and blood vessels (Iadecola, 2004). In fact, the CBF response to neural activity
is very rapid and is restricted to the region of activation (Iadecola, 2004). The cellular
mechanisms that are responsible for this activation-flow coupling are not entirely
understood due, in part, to the complex signaling mechanisms between the structures of
the neurovascular unit (Iadecola, 2004). One view that has long been a focus of
understanding the activation-flow coupling, is the release of vasoactive agents (Iadecola,
1993, 2004). Furthermore, the release of neurotransmitters that are not vasoactive have
been linked to the production of vasodilators such as NO (Bhardwaj et al., 2000; Faraci &
Breese, 1993) and adenosine (Iliff, D'Ambrosio, Ngai, & Winn, 2003). Attempts to
uncover the predominant mediators of the hyperemic response have been unsuccessful as
inhibition of any one mediator may lessen, but not eradicate, the hyperemic response
(Iadecola, 1993, 2004). Furthermore, it has been noted that the attenuation of the CBF
response with the inhibition of mediators varies by the region of the brain studied (Gotoh
et al., 2001; Hayashi et al., 2002; Yang, Chen, Ebner, & Iadecola, 1999; Yang, Zhang,
Ross, & Iadecola, 2003).
Recently, strong support for the importance of astrocytes in the activation-flow
coupling has emerged (Zonta et al., 2003). The rapid CBF response can be attributed to
the functional coupling of neurons and astroctyes and the direct contact of the astrocytic
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end-feet with the smooth muscle cells of the penetrating arterioles and the pericytes of the
capillaries (Figure 2.2; (Iadecola, 2004). The astrocytic end-feet release several
vasoactive agents including, but not limited to, potent vasodilators such as NO and
adenosine (Nedergaard, Ransom, & Goldman, 2003; Paulson & Newman, 1987).
Furthermore, Zonta and colleagues (2003) observed the production of calcium in
astrocytes that was linked to the release of glutamate from neurons. The calcium travelled
to the astrocytic end-feet where subsequent vascular dilation was witnessed (Zonta et al.,
2003).

Figure 2.2: The interaction between astrocytes and the cerebral arterioles. The astrocytic
end-feet are in direct contact with the smooth muscle cells of the penetrating arterioles
and the pericytes of the capillaries. As a result, the astrocytes exert a high level of control
over the vasomotor tone of the cerebral vessels and consequently, the regulation of CBF.
Iadecola & Nedergaard (2007) Glial regulation of the cerebral microvasculature. Nature
Neuroscience 10 (11): 1369-1376.
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2.3.3

Neural Control

The cerebral vasculature is densely innervated by adrenergic and cholinergic fibres that
originate from extrinsic or intrinsic sources, depending on the vessel location (Bleys,
Cowen, Groen, Hillen, & Ibrahim, 1996; Hamel, 2006). Extrinsic origins include the
superior cervical ganglion, sphenopalatine and otic ganglia, or the trigeminal ganglion
(Hamel, 2006). The superior cervical ganglion yields sympathetic nerve fibres releasing
norepinephrine (NE) and neuropeptide Y (Hamel, 2006). In contrast, the sphenopalatine
and otic ganglia yield parasympathetic nerve fibres releasing acetylcholine (ACh) and
NO along with other vasoactive agents (Hamel, 2006). The trigeminal ganglion provides
sensory nerves that releases, among others, calcitonin gene-related peptide, a potent
vasodilator (Hamel, 2006). This pathway is thought to act as a protective mechanism
returning vessel tone to resting levels following vasoconstrictor stimuli (Hamel, 2006).
Intrinsic origins include the nucleus basalis, locus coeruleus, and the raphe nucleus
(Hamel, 2006). The nucleus basalis releases the parasympathetic mediator ACh and the
locus coeruleus provides the sympathetic mediator NE (Hamel, 2006). The raphe nucleus
releases 5-HT, or serotonin, which plays a major role in microvascular tone, largely
appearing to have a vasoconstrictor effect (Cohen, Bonvento, Lacombe, & Hamel, 1996;
Hamel, 2006).
Human studies have evaluated the role of the sympathetic nervous system (SNS)
in CBF though they have been limited to various patient populations requiring
ganglionectomy or the use of various ganglion blockade techniques in patient populations
and in healthy adults (C. K. Willie et al., 2014). Investigations employing ganglion
excision in patients have demonstrated increases in CBF (Jeng, Yip, Huang, & Kao,
1999; Shenkin, 1969; Shenkin, Cabieses, & Van Den Noordt, 1951). However, with local
cervical ganglion blockades, the results were equivocal with some studies showing an
increase in CBF (K Ide et al., 2000; Treggiari et al., 2003; Umeyama et al., 1995;
Yokoyama, Kishida, & Sugiyama, 2004), other studies showing no change in CBF
(Harmel, Hafkenschiel, Austin, Crumpton, & Kety, 1949; Ohta, Hadeishi, & Suzuki,
1990; Scheinberg, 1950), and one investigation showing a decrease in CBF (Kang et al.,
2010). The inconsistency in the results of the ganglion blockade investigations could be
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explained by the variations in populations investigated or by the use of subcutaneous
blockade strategies where it is difficult to obtain full blocks of the targeted ganglia (C. K.
Willie et al., 2014). Despite the equivocal data of the ganglion blockade studies, all
investigations employing ganglionectomy showed increased CBF clearly demonstrating
the influence of the SNS on CBF, at least under baseline conditions (C. K. Willie et al.,
2014). Additionally, animal experiments (Cassaglia, Griffiths, & Walker, 2008a, 2008b,
2009) and human studies (Ainslie, 2009; Mayhan, Werber, & Heistad, 1987; Y.-C. Tzeng
et al., 2010) have provided evidence for the importance of the SNS during alterations in
ABP, particularly under conditions of increased CPP. In situations of high CPP,
sympathetic constriction of the large cerebral arteries protects downstream circulation
(Mayhan et al., 1987).
The level of influence the parasympathetic nervous system (PNS) exerts over
CBF has rarely been studied. One previous investigation employed the stimulation of the
basal forebrain, observing an increase in CBF (Hamel, 2006). However, after blockade of
the muscarinic M5 receptors or following the inhibition of NO synthase, the increase in
CBF witnessed with basal forebrain stimulation was attenuated (Hamel, 2006). The
results of this investigation provide some evidence of PNS influence over CBF.

2.3.4

Blood Pressure and Cerebral Autoregulation

CA is a homeostatic mechanism that works to preserve CBF in the face of fluctuations in
CPP (N. A. Lassen, 1959). Through vasomotor adjustments, CA is able to maintain CBF
at relatively constant levels when CPP is within the range of 50 mmHg to 150 mmHg (N.
A. Lassen, 1959). Beyond the lower and upper boundaries of autoregulation, vasomotor
adjustments can no longer occur and CBF passively follows changes in CPP (Len &
Neary, 2011; R. B. Panerai, 1998; Udomphorn et al., 2008). The autoregulation
boundaries are not completely fixed and shifts in the boundaries are thought to take place
in conditions where changes in metabolism occur such as altering PaCO2 and chronic
hypertension (R. B. Panerai, 1998; Van Beek et al., 2008).
Regulation of CA occurs through myogenic, neurogenic and metabolic
mechanisms (R. B. Panerai, 2008; Rangel-Castilla, Gasco, Nauta, Okonkwo, &
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Robertson, 2008; Y.-C. Tzeng & Ainslie, 2014; Vrselja et al., 2014). The myogenic
response is initiated from the vascular smooth muscle in response to changes in
transmural pressure across the vessel wall (Rangel-Castilla et al., 2008; Y.-C. Tzeng &
Ainslie, 2014). Following increases in blood pressure, the vascular smooth muscle is
stretched leading to the activation of stretch-sensitive ion channels (Clifford, 2011; Y.-C.
Tzeng & Ainslie, 2014). Activation of the ion channels initiates membrane depolarization
and the movement of calcium into the vascular smooth muscle through voltage-gated
calcium channels consequently leading to constriction of the vessel (Clifford, 2011; Y.-C.
Tzeng & Ainslie, 2014). In contrast, with decreases in blood pressure the opposite occurs
resulting in vasodilation (Clifford, 2011; Y.-C. Tzeng & Ainslie, 2014). To test the role
of extracellular calcium in the myogenic response, studies have employed calcium
channel blockades, via nimodipine and nicardipine, during oscillatory lower body suction
to induce pressure-dependent oscillations in CBF (Tan, Hamner, & Taylor, 2013; Y. C.
Tzeng, Chan, Willie, & Ainslie, 2011). Using transfer function analysis (TFA),
Windkessel modeling, and regression analytical techniques, the investigations found
diminished autoregulatory responses following calcium channel blockade (Tan et al.,
2013; Y. C. Tzeng et al., 2011). These data would suggest that the myogenic mechanism
does exert influence over CA.
Investigations evaluating the neural control of CA have largely focused on animal
models though, more recently human investigations have supported the role of
neurogenic factors in CA (Y.-C. Tzeng & Ainslie, 2014). Kimmerly and colleagues
(2003) evaluated CA following the infusion of both norepinephrine and phentolamine.
The infusion of norepinephrine, an alpha-adrenergic receptor agonist, increased MAP
though MCA velocity remained relatively unchanged demonstrating intact autoregulation
(Kimmerly et al., 2003). However, phentolamine, an alpha-adrenergic receptor
antagonist, co-infused with norepinephrine caused a significant drop in MAP and MCA
flow velocity, indicating an impairment to CA (Kimmerly et al., 2003). This evidence for
impaired CA following alpha-adrenergic receptor blockade suggests a role of the SNS in
CA (Kimmerly et al., 2003). Furthermore, Zhang and colleagues (2002) evaluated
dynamic CA before and after ganglion blockade with trimethaphan. Following ganglion
blockade, a large increase in transfer function gain and a reduction in the phase lead of
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CBFV to ABP occurred suggesting an impairment in CA (Zhang et al., 2002). Though,
ganglion blockades disrupt both sympathetic and parasympathetic nerve activity so it is
not clear whether sympathetic and/or cholinergic influences affected CA in this model
(Zhang et al., 2002).
Metabolites in the vascular endothelium have also been recognized to contribute
to the autoregulatory response (R. B. Panerai, 2008; Y.-C. Tzeng & Ainslie, 2014; Van
Beek et al., 2008). In particular, NO has garnered much attention given its role as a potent
dilatory stimulus in the cerebral circulation (Faraci & Brian, 1994; Faraci & Heistad,
1998). The infusion of L-NMMA to block endothelial NO production resulted in a
weakened autoregulatory response suggesting a contribution of endothelial NO to CA
(White, Vallance, & Markus, 2000). Furthermore, animal research using L-NMMA
infusion found similar results (Faraci & Brian, 1994). However, previous investigations
have also provided evidence that inhibition of endothelial NO has no effect on CA
(Faraci & Brian, 1994; Y.-C. Tzeng & Ainslie, 2014). Given the equivocal results, the
exact role of NO remains unclear though it is considered to exert some level of influence
over CA (Faraci & Brian, 1994; Rangel-Castilla et al., 2008; Y.-C. Tzeng & Ainslie,
2014).
Unfortunately, the cerebral vasculature cannot be entirely isolated from other
influences preventing investigators from determining the relative contribution of the
myogenic mechanism, neurogenic factors, and metabolic factors in CA (Y.-C. Tzeng &
Ainslie, 2014).

2.3.4.1

Static Cerebral Autoregulation

Static CA looks at the association between mean CBF and mean arterial blood pressure
(MABP) following induced alterations or spontaneous changes in ABP (R. B. Panerai,
1998). With this approach measures are taken in steady-state (Tiecks et al., 1995). Static
CA studies are the foundation for the classical autoregulation curve (N. A. Lassen, 1959).
Lassen discovered the autoregulation curve after combining the results from multiple
studies where the species investigated and the methodology employed varied (R. B.
Panerai, 1998; Van Beek et al., 2008). Nonetheless, the classical autoregulation curve
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continues to be the dominant model of cerebral autoregulation (R. B. Panerai, 1998). Few
studies have since evaluated the relationship between ABP and indices of CPP over long
durations and, with various statistical techniques, have found autoregulation curves
similar to that outlined by Lassen (Czosnyka et al., 2001; Tan, 2012).
Static CA evaluates steady-state ABP and CBF before and after inducing a change
in ABP (R. B. Panerai, 1998; Rangel-Castilla et al., 2008; Tiecks et al., 1995). By this
approach, the initial period following the alteration in ABP is ignored, when ABP and
CBF are changing dynamically (R. B. Panerai et al., 2001; Tiecks et al., 1995). As a
result, static CA provides information on the absolute change in CBF for a given change
in ABP but overlooks the time course of the autoregulatory response (R. B. Panerai,
1998; R. B. Panerai et al., 2001; Tiecks et al., 1995). Techniques commonly used to
induce changes in ABP include drug infusion, head-up-tilt (HUT), and lower body
negative pressure (LBNP) (R. B. Panerai, 1998). Because steady-state ABP and CBF are
required, static CA assessments tend to be time-consuming (Tiecks et al., 1995).
Therefore, static CA may not be the most practical method for assessing cerebrovascular
function in clinical settings.

2.3.4.2

Dynamic Cerebral Autoregulation

Dynamic CA evaluates dynamic changes in CBFV in response to rapid, transient changes
in ABP (Aaslid et al., 1989). Assessment of dynamic CA is only possible with continuous
measures of CBFV from TCD providing information on the adaptive period following
alterations in ABP (Aaslid et al., 1989). Therefore, dynamic CA provides information on
the time course of the autoregulatory response (Tiecks et al., 1995; M. Vavilala et al.,
2002). Previous research has proposed that the time course of the autoregulatory response
is affected first in various pathological conditions suggesting the importance of dynamic
CA measures (Tiecks et al., 1995). The rapid nature of dynamic CA assessments may be
useful in evaluating cerebrovascular function in clinical settings given the proper tools
and analysis processes are accessible.
Appropriate methodology is necessary to induce rapid, transient changes in ABP.
The thigh-cuff model was derived by Aaslid and colleagues (1989) and has been most
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commonly employed by investigations evaluating dynamic CA (R. B. Panerai, 1998).
The thigh-cuff model involves the inflation of two large blood pressure cuffs around both
thighs to suprasystolic levels (Aaslid et al., 1989). The thigh-cuffs remain inflated for two
minutes before being deflated rapidly thereby producing a rapid drop in ABP (Aaslid et
al., 1989). The thigh-cuff model requires a number of repeated trials due to high
variability in the ABP drop (Sorond, Serrador, Jones, Shaffer, & Lipsitz, 2009). Repeated
cuff inflations are often quite painful for participants making it difficult to complete the
desired number of trials (Lipsitz, Mukai, Hamner, Gagnon, & Babikian, 2000; Sorond et
al., 2009). Due to the limited clinical applicability of the thigh-cuff model, particularly in
certain populations, additional models have recently been developed as an alternative
(Sorond et al., 2009). One model that was developed is the sit-to-stand model (Lipsitz et
al., 2000). The sit-to-stand model, as originally described by Lipsitz et al. (2000),
involves sitting in a straight-backed chair with legs at 90 degrees for five minutes
followed by standing for one minute. The sit-to-stand test is well-tolerated and can be
performed effectively in elderly populations (Sorond, Khavari, Serrador, & Lipsitz, 2005;
Sorond et al., 2009). This model induces a consistent and reproducible drop in MAP,
similar to that of a successful thigh-cuff trial (Sorond et al., 2009). In addition, the sit-tostand protocol is a more relevant physiological stimulus and may be more suitable for
clinical use particularly in certain populations (Sorond et al., 2005; Sorond et al., 2009).
Dynamic CA can be evaluated using the rate of regulation (RoR) or the dynamic
autoregulatory index (ARI) (Aaslid et al., 1989; Tiecks et al., 1995). The RoR was
originally derived from the thigh-cuff model and represents the per-second adjustment of
the CVR response necessary to compensate for the change in ABP (Aaslid et al., 1989).
Following the deflation of the thigh-cuffs, a drop in ABP, CBFV, and CVR occur. The
rate of change in CVR (∆CVR/∆T) is calculated during the time interval from 1 to 3.5
seconds following cuff deflation (Aaslid et al., 1989). The change in ABP (∆ABP) is
determined as the difference between the control ABP, defined by the mean during the 4
seconds prior to cuff release, and the mean ABP during the interval from 1 to 3.5 seconds
(Aaslid et al., 1989). This value is then divided by the control ABP (Aaslid et al., 1989).
The RoR is then defined as the rate of change in CVR relative to the change in ABP
((∆CVR/∆T)/∆ABP) (Aaslid et al., 1989). Though this approach was originally derived
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from the thigh-cuff deflation model, the sit-to-stand model produces similar responses
(Sorond et al., 2009); therefore, RoR theoretically should be applicable to both models.
The dynamic ARI was also derived from the thigh-cuff deflation model (Tiecks et
al., 1995). This approach is based on a computer model that calculated ten hypothetical
curves for the CBFV responses to a 30 second drop in ABP. First, a hypothetical curve
for CBFV was computed assuming autoregulation was absent and was associated with an
ARI value of 0 (Tiecks et al., 1995). Nine additional curves were computed, each
assigned an ARI value of 1 through 9 (Tiecks et al., 1995). The actual CBFV response
witnessed in the experiment is fitted to one of the ten curves and the associated ARI
values signifies the strength of the autoregulatory response with 0 being absent
autoregulation and 9 being optimal autoregulation (Tiecks et al., 1995). Normal ARI
values were reported to be 5 ± 1 (Tiecks et al., 1995). This approach has also been
applied in the sit-to-stand model (Sorond et al., 2009).

2.3.4.3

Cerebral Autoregulation and Carbon Dioxide

Similar to the cerebral circulation, PaCO2 has a profound effect on CA that is witnessed
for static and dynamic CA. With respect to static CA, the boundaries of the
autoregulation curve are adjusted in response to alterations in PaCO2 (Aaslid et al., 1989;
Edwards, Shoemaker, & Hughson, 2002; Meng & Gelb, 2015; R. Panerai, Deverson,
Mahony, Hayes, & Evans, 1999; R. B. Panerai, 1998; Ursino & Lodi, 1998). During
hypercapnia, the autoregulation curve is shifted upwards to a higher CBF (R. Panerai et
al., 1999; R. B. Panerai, 1998; Ursino & Lodi, 1998) and the upper and lower limits are
shifted leftwards and rightwards, respectively, narrowing the plateau region of the curve
(Meng & Gelb, 2015; R. B. Panerai, 1998). At very high levels of PaCO2, the plateau
region dissipates and cerebral autoregulation is no longer functional (R. Panerai et al.,
1999; R. B. Panerai, 1998). In contrast, the autoregulation curve is shifted downwards
during hypocapnia (Meng & Gelb, 2015; Ursino & Lodi, 1998) and the plateau region
widens (R. Panerai et al., 1999). One investigation has reported that the upper limit shifts
rightwards and the lower limit shifts leftwards (R. Panerai et al., 1999). However, a
second investigation has described only moderate changes in the lower limit with changes
in the upper limit unclear (Meng & Gelb, 2015). Though the exact alterations in the
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boundaries of autoregulation with hypocapnia remain unknown, low PaCO2 does shift
the autoregulatory curve down (Aaslid et al., 1989; Edwards et al., 2002; R. Panerai et al.,
1999).
With respect to dynamic CA, Aaslid and colleagues (1989) evaluated the effect of
PaCO2 on RoR in a group of healthy adults. Hypercapnia produced a reduction in
autoregulatory capacity from normocapnia slowing the RoR (Aaslid et al., 1989). In
contrast, hypocapnia enhanced the autoregulatory response, increasing the RoR (Aaslid et
al., 1989).

2.3.4.4

Cerebral Autoregulation and Head Injury

Cerebral autoregulatory outcomes following head injury have become an area of interest
in recent decades, particularly with recent increases in concussion incidence (Stewart et
al., 2014). Many investigations have focused on adults suffering from moderate to severe
TBI (Bailey et al., 2013; Czosnyka et al., 2001; Lang et al., 2003; Lee et al., 2001). In
contrast, pediatric populations and patients suffering from concussion have seldom been
studied. Furthermore, the investigation of CA in head injury have largely employed static
measures of CA (Czosnyka et al., 2001; Lang et al., 2003; Lee et al., 2001).
One of the earlier investigations into CA following head injury was conducted in
adults admitted to the hospital for minor head injury (Jünger et al., 1997). Minor head
injury was defined by a Glasgow Coma Scale (GCS) score of 13 to 15 and participants
were treated with bed rest, analgesic medications, and intravenous administration of
crystalloid solutions (Jünger et al., 1997). Loss of consciousness was not reported in this
investigation (Jünger et al., 1997). Participants completed dynamic CA testing with the
thigh-cuff deflation model within 48 hours of the concussive injury (Jünger et al., 1997).
To evaluate CA, dynamic ARI was calculated and similar ARI values were witnessed for
the head-injured patients and the healthy controls (Jünger et al., 1997). However, the
head-injured patients appeared to present as two distinct groups, one with relatively
normal ARI values and one with low ARI values (Jünger et al., 1997). Therefore,
impairments in dynamic CA were witnessed in some but not all adults with minor head
injury (Jünger et al., 1997).
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In 2001, Czosnyka and colleagues examined the associations between CA and
ABP, CPP, and ICP in adults suffering from severe TBI with an average GCS value of 6
(Czosnyka et al., 2001). Recordings of ABP, CPP, and ICP waveforms were captured
over a period from 20 minutes to 120 minutes (Czosnyka et al., 2001). To evaluate static
CA, the mean index of autoregulation (Mx) was calculated as a Pearson correlation
coefficient of CPP and CBFV with positive associations indicating impaired
autoregulation (Czosnyka et al., 2001). The relationship between Mx and ABP was
described by a U-shaped curve with weaker autoregulation observed at low ABP and at
high ABP (Czosnyka et al., 2001). Similarly, a U-shaped curve was also seen for the
relationship between Mx and CPP with weaker autoregulation observed at low CPP and
at high CPP (Czosnyka et al., 2001). Autoregulation and ICP were inversely related, such
that the autoregulatory response was weakened with increasing ICP (Czosnyka et al.,
2001). The results of this investigation provided information on a range of ABP, CPP,
and ICP within which static CA was optimized in severe TBI (Czosnyka et al., 2001).
Lee and colleagues (2001) measured static CA in moderate to severely headinjured patients presenting with a mean GCS score of 7. An elevation in ABP was
induced following the infusion of phenylephrine (Lee et al., 2001). The average ABP and
CBFV before and after phenylephrine infusion were used to estimate CVR (Lee et al.,
2001). A pressure autoregulation index was calculated as the percent change in estimated
CVR divided by the percent change in MAP (Lee et al., 2001). Similar to the
investigation by Jünger and colleagues (1997), a variable impairment was observed in
static CA (Lee et al., 2001). In addition, participants were assessed over the course of six
days (Lee et al., 2001). No differences were seen in static CA between time points though
there did appear to be a trend towards improvement after four days’ post-injury (Lee et
al., 2001).
Lang and colleagues (2003) also evaluated the temporal profile of static CA in
adults suffering from moderate to severe TBI. The participants presented with an average
GCS score of 7 and measures of ABP and CBFV were collected over a period of
approximately 18 minutes (Lang et al., 2003). To evaluate static CA, Mx was calculated
and impaired CA was defined as values greater than 0.3 (Lang et al., 2003). No
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impairments in static CA were witnessed though there appeared to be a trend towards
deficits in autoregulation immediately after injury. This remained throughout the first
three days of recovery and improvements began between four and six days post-injury
(Lang et al., 2003).
More recently, static and dynamic CA were examined in professional boxers who
experienced repeated sub-concussive head impacts (Bailey et al., 2013). The control
participants were matched with the boxers for age and physical fitness levels (Bailey et
al., 2013). This investigation utilized two methods of evaluating dynamic CA; RoR and
ARI were calculated following thigh-cuff deflation (Bailey et al., 2013). In addition,
static CA was measured with TFA (Bailey et al., 2013). For TFA, steady-state ABP and
CBFV were collected over a period of 5 minutes (Bailey et al., 2013). No differences
were observed in static CA between the boxers and the healthy controls (Bailey et al.,
2013). However, with the thigh-cuff deflation model, the boxers demonstrated lower RoR
and ARI values when compared with the healthy controls (Bailey et al., 2013). Therefore,
although static CA remained intact in the boxers, impairments in dynamic CA were
observed (Bailey et al., 2013). This investigation demonstrates the importance of
employing dynamic measures of CA in head-injured patients.
As previously mentioned, the pediatric population remains poorly studied with
respect to CA and head-injury. To date, only two studies have investigated static CA in
pediatric TBI (Muizelaar et al., 1989; M. S. Vavilala et al., 2004). Muizelaar and
colleagues (1989) measured static CA in severely head-injured children presenting with
an average GCS score of 5.5. Following the infusion of phenylephrine, ABP was
increased by approximately 30% (Muizelaar et al., 1989). In some instances, if CBF was
normal or high and if motor evoked potentials could be monitored continuously, ABP
was lowered with the infusion of trimethaphan camsylate (Muizelaar et al., 1989). Static
CA was evaluated as %CPP/%CVR and impaired CA was defined as a value greater than
2 (Muizelaar et al., 1989). On the other hand, Vavilala and colleagues (2004) assessed
three groups of children that were divided based on injury severity using the GCS. Group
one included patients with severe TBI defined by a GCS score below 9, group two
included moderate TBI patients defined by a GCS score of 9-12, and group three
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included mild TBI patients defined by GCS score of 13-15 (M. S. Vavilala et al., 2004).
Participants were under general anesthesia for extracranial surgical procedures (M. S.
Vavilala et al., 2004). Phenylephrine was infused over a period of 3 to 5 minutes and
ABP was raised to specific criteria based on age (M. S. Vavilala et al., 2004). Static CA
was evaluated using static ARI calculated as %∆CVR/%∆MAP, where 0 represents
absent autoregulation and 1 represents optimal autoregulation (M. S. Vavilala et al.,
2004). In this investigation, intact autoregulation was defined as an ARI ≥ 0.4 (M. S.
Vavilala et al., 2004). Both investigations found only variably impaired static CA in
children and adolescents following mild to severe TBI (Muizelaar et al., 1989; M. S.
Vavilala et al., 2004). To date, measures of static or dynamic CA have not been
performed in adolescent concussion.

2.4 Summary and Purpose
Concussion is a major concern in adolescent populations though very little data exist on
cerebrovascular outcomes following concussive injuries in this population. Therefore,
there is a strong need to evaluate CA in adolescent concussion provided the importance
of this homeostatic mechanism in CBF regulation and consequently maintenance of
cerebral perfusion to meet the metabolic demands of the brain. Previous investigations of
CA in the pediatric population have largely employed static measures (Muizelaar et al.,
1989; M. S. Vavilala et al., 2004). However, as the investigation by Bailey et al. (2013)
demonstrated, it is important to evaluate the dynamic, adaptive responses of the cerebral
circulation to hemodynamic stress. Therefore, the purpose of this investigation was to
evaluate dynamic cerebral autoregulatory function in adolescents diagnosed with a
concussion. This study tested the hypothesis that concussed adolescents would be
marked by impaired dynamic autoregulatory responses.
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Chapter 3

3

Methods

3.1 Participants
Thirty adolescents diagnosed with a concussion (15 ± 1 years; 20 females) and thirty
healthy controls (14 ± 2 years; 15 females) participated in the current investigation.
Participants were between the ages of 12 and 18 years and were actively involved in
sports and recreational activities. In total, eleven participants were on various
medications for asthma and exercise-induced asthma (Ventolin, n=7; Flovent, n=1),
depression (Cipralax, n=1), ADHD (Strattera, n=1), hyperthyroidism (Tapazole, n=1),
headaches (Amitriptyline, n=1), and anxiety (Sertraline, n=1). In addition, a total of six
female participants were on oral contraceptives.
Concussed adolescents were recruited upon diagnosis by a physician at the
Fowler Kennedy Sports Medicine Clinic (FKSMC) and control participants were
recruited from various athletic organizations within the community. Control participants
with a previous history of concussion were included provided the injury was not within 6
months of their initial visit and they were no longer experiencing persistent symptoms
(n = 8).
Potential participants were excluded if they had existing bone or muscle problems
that could impact balance or gait, diagnosis of a pre-existing heart disease, use of betablockers or anticonvulsants or any other medications that affect heart or blood pressure
control, significant respiratory disease or illness, any pre-existing neurological disorders,
metabolic disorders such as diabetes, a history of significant neck injury, Rheumatoid
arthritis, vertebral basilar artery insufficiency, primary or metastatic bone tumor, severe
osteoporosis, inability to understand English, diagnosis of post-traumatic stress disorder,
and/or pregnancy.
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All participants provided written informed consent and received detailed
explanations of all experimental protocols prior to participation. The study was approved
by the Health Sciences Research Ethics Board at Western University.

3.2 Experimental Protocols
Healthy controls participated in up to two laboratory sessions separated by at least one
week. Concussed adolescents participated in laboratory sessions weekly or biweekly, for
up to six visits or until medical clearance was granted by a physician at FKSMC.
Identical testing procedures were followed at each laboratory session.
At the initial laboratory session, participants provided a detailed medical history.
Concussed adolescents further provided detailed information concerning the injury
including etiology and initial symptomology. Participants with a previous history of
concussion provided similar details of past injuries along with specific information on the
length of recovery and the history of symptoms following recovery. At each subsequent
visit, participants provided a medical update documenting any changes to their health or
medications. For the concussed adolescents, details about their progress as well as current
rehabilitative approaches being followed were documented.
To outline their symptom profile at the time of testing, participants completed the
Sport Concussion Assessment Tool - 3rd edition (SCAT3) self-report symptom
evaluation. The SCAT3 symptom evaluation includes a total of 22 symptoms that are
rated on a scale of 0 to 6 with a maximum symptom severity score of 132. A Child
SCAT3 is completed for children 12 and younger and differs from the SCAT3 in the
number of symptoms, the description of symptoms, and in the severity scale ranging from
0 to 3. Additionally, participants completed the Generalized Anxiety Disorder 7-item
Scale (GAD-7) to provide details on the levels of anxiety generally experienced over the
two-week period prior to the testing session. Participants also completed a visual
analogue scale (VAS) of anxiety to identify levels of anxiety at the time of testing. The
VAS utilized in the present investigation was developed by our laboratory in conjunction
with the FKSMC and is shown in Figure 3.1. To provide information on pubertal
development, participants completed the Tanner Puberty Stages Questionnaire. Female
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participants answered additional question regarding menstrual cycle including age of
menarche, frequency of menstruation, day of menstrual cycle, and whether participants
were on oral contraceptives. Furthermore, anthropometric measures were recorded and
three baseline blood pressure measurements were collected in a seated position with a
manual sphygmomanometer.
Participants were instrumented with a standard 3-lead electrocardiogram (ECG)
for continuous measures of heart rate (HR) and a finger photoplethysmograph
(Finometer, Finapres Medical Systems BV, Amsterdam, The Netherlands) for continuous
measures of ABP. Stroke volume (SV) and cardiac output (CO) were obtained using the
Finometer Modelflow algorithm that accounts for participant sex, age, height, and
weight. Breathing frequency and PETCO2 were monitored continuously with a respiratory
strain gauge and a gas analyzer (ML206, ADInstruments, Colorado Springs, CO, USA),
respectively.
Following completion of a 5-minute baseline recording period in the supine
position, participants were assisted into a seated position in a chair for the sit-to-stand
protocol. Participants were fitted with a sling to maintain the right arm in a fixed position
at the level of the heart thereby eliminating hydrostatic pressure effects during the
postural changes (Lipsitz et al., 2000). Participants were equipped with a bilateral
monitoring headband device (Neurovision 500M, Neurovision TOC2M, Multigon
Industries, Elmsford, CA, USA) and the right MCA was insonated through the
transtemporal window and CBFV recorded (2 MHz PW Doppler probe, Neurovision
500M, Neurovision TOC2M, Multigon Industries, Elmsford, CA, USA). Mean flow
velocity was collected for twenty-seven participants (13 concussed adolescents and 14
healthy controls) and peak flow velocity was collected for thirty-three participants (17
concussed adolescents and 16 healthy controls).
For the sit-to-stand protocol, participants rested in the seated position for three
minutes then transitioned to a standing position for two minutes. Participants then
resumed the seated position and the protocol was repeated. The transition to standing and
sitting was done without the use of hands.
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Figure 3.1: Visual analogue scale of anxiety. The scale was used to measure the
participants’ levels of anxiety at the time of testing.

3.3 Data Analysis
The brachial blood pressure waveform was corrected to manual sphygmomanometric
values. Hemodynamic and respiratory measures were evaluated in the supine, sitting, and
standing postures. Measures of steady-state ABP, HR, CO, SV, total peripheral resistance
(TPR), PETCO2, and respiration frequency were averaged during the five-minute supine
period, the full three-minute sitting periods, and the full two-minute standing periods.
TPR was calculated as mean arterial pressure (MAP) divided by CO. Measures of steadystate CBFV and CVR were averaged only during the full three-minute sitting periods and
the full two-minute standing periods as this data was not collected during the supine
posture.
In addition, the initial dynamic changes in the hemodynamic and respiratory parameters
with standing were assessed (Figure 3.2). The control values for each hemodynamic
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parameter was defined as the mean value in the four seconds of sitting prior to standing.
The four seconds of sitting prior to standing was representative of the full sitting period
for all hemodynamic and respiratory parameters. The absolute change in MABP, CBFV,
CVR, SV, and TPR, was calculated as the difference between the control value and the
nadir value after standing. For HR and CO, the absolute change was calculated as the
difference between the control value and the peak value after standing. Upon
transitioning to standing, PETCO2 continues to fall throughout the remainder of the
standing period. Therefore, the absolute change in PETCO2 was evaluated as the
difference between the control value and the mean value during the interval in which the
reduction in CVR occurred.
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Time (s)

Figure 3.2: Measurement of dynamic changes in the hemodynamic and respiratory
parameters with standing. Sample data from concussed participant. ABP, arterial blood
pressure; CBFV, cerebral blood flow velocity; CVR, cerebral vascular resistance;
PETCO2, end tidal carbon dioxide partial pressure; CO, cardiac output; HR, heart rate;
SV, stroke volume; TPR, total peripheral resistance. The control values were defined as
the mean value in the four seconds of sitting prior to standing. Initial absolute changes
were evaluated as the difference between the control values and the nadir values (ABP,
CBFV, CVR, SV, TPR) or peak values (CO, HR). The difference in PETCO2 was
evaluated using the mean value during the interval in which CVR is reduced.
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The time course of the changes in the hemodynamic parameters with standing was
evaluated (Figure 3.3). The time to nadir was assessed for MABP, CBFV, CVR, and TPR
by measuring the time from standing to the nadir value. In contrast, the time to peak HR
was evaluated by calculating the time from standing to the peak value. In addition, the
time to peak MABP and CBFV was evaluated by calculating the time from standing to
the peak value following the initial reduction. Furthermore, the delay in the
cerebrovascular response was evaluated. The time to CVR drop was assessed as the time
from standing to the initiation of the CVR drop.
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Figure 3.3: Measurement of the time course of changes in the hemodynamic parameters
with standing. Sample data from concussed participant. ABP, arterial blood pressure;
CBFV, cerebral blood flow velocity; CVR, cerebral vascular resistance; PETCO2, end
tidal carbon dioxide partial pressure; CO, cardiac output; HR, heart rate; SV, stroke
volume; TPR, total peripheral resistance. Time to nadir was measured from the time of
standing to the nadir value (red arrows) and time to peak was measured from the time of
standing to the peak value (blue arrows). The time to CVR drop was measured from the
time of standing to the initiation of the drop in CVR (green arrow).
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To evaluate cerebral autoregulation, RoR was calculated as previously described
by Aaslid et al. (1989) with modifications for application to the sit-to-stand model
(Figure 3.4). Control values of ABP and CBFV were defined by their means in the four
seconds of sitting prior to standing. Subsequent changes in ABP and CBFV with standing
were calculated relative to the control values. The CVR was determined as ABP divided
by CBFV. Upon standing, a drop in CVR occurred and the change in CVR was measured
from the initiation of the drop, or the maximum value, to the nadir value (∆CVR). A
regression line was computed and the slope of the line defined the rate of change in CVR
(∆CVR/∆T). RoR represents the per second adjustment of the CVR response required to
fully compensate for the drop in ABP. Thus, RoR is defined as the rate of change in CVR
relative to the change in ABP ((∆CVR/∆T)/∆ABP). The change in ABP (∆ABP) is
calculated by subtracting the control ABP from the mean ABP during the interval in
which CVR is reduced; this value is then divided by the control ABP.
Sit-to-stand trials were excluded if the drop in MABP was less than 12 mmHg
(M. Vavilala et al., 2002), if the ABP or CBFV signals were lost during the protocol, or if
the CBFV signal was uninterpretable. Noisy CBFV tracings with signal spikes or
dropouts were smoothed through a low-pass filter (10-50 Hz). Two sit-to-stand trials
were completed and participants with two adequate sit-to-stand trials were included in the
data analysis. In total thirty-eight participants were excluded from analysis.
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RoR = (∆CVR/∆T)/ ∆ABP

Time (s)

Figure 3.4: Measurement of the rate of regulation with a sit-to-stand model. Sample data
from concussed participant. ABP, arterial blood pressure; CBFV, cerebral blood flow
velocity; CVR, cerebral vascular resistance. Relative changes in ABP and CBFV were
calculated by dividing ABP and CBFV by the control values in the four seconds of sitting
prior to standing. CVR is calculated by dividing ABP by CBFV. The change in CVR is
measured and the slope of the line (∆CVR/∆T) is divided by the change in ABP (∆ABP)
to provide RoR ((∆CVR/∆T)/∆ABP).
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3.4 Statistical Analysis
Data are presented as mean ± SD, unless otherwise indicated. SigmaPlot 12.5 and SPSS
Statistics 23 were used for statistical analysis. Participant characteristics were evaluated
between the healthy controls and the concussed adolescents using unpaired t-tests.
Further, supine hemodynamic and respiratory parameters were compared between the
healthy controls and the concussed adolescents using unpaired t-tests. Comparisons of
steady-state sitting and standing hemodynamic and respiratory parameters between the
healthy controls and concussed adolescents were made with a two-way repeated
measures ANOVA. The initial absolute changes in the hemodynamic parameters with
standing and the time course of these changes were compared between the two groups
using unpaired t-tests. Comparison of RoR between the healthy controls and the
concussed adolescents were made with unpaired t-tests. In this approach, the healthy
controls acted as a reference group to which the concussed adolescents were compared at
the first and final visit and a Bonferroni correction was applied. Significance was set as P
≤ 0.05.
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Chapter 4

4

Results

4.1 Participant Characteristics and Supine Hemodynamic
and Respiratory Parameters
Participant physical characteristics and supine hemodynamic and respiratory data are
presented in Table 4.1. Participant physical characteristics, including age, height, weight,
and body mass index (BMI), were not statistically different between the concussed
adolescents and healthy controls. The concussed adolescents sustained their injury
through participation in sports and recreational activities and attended the laboratory for
their initial visit, on average, 26 ± 19 days’ post-injury. Notably, the concussed
adolescents were largely in the acute phase of recovery at the time of their initial visit (17
± 12 days post-injury) with the exception of six participants whose initial visit was
greater than 42 days’ post-injury classifying them as PCS (58 ± 11 days post-injury)
(Willer & Leddy, 2006). Compared with the healthy controls, the concussed adolescents
collectively scored higher on the SCAT-3 symptom evaluation at the initial visit for both
the number of symptoms experienced (P ≤ 0.001) and the severity of symptoms (P ≤
0.001). One control participant was excluded from the SCAT-3 analysis as they
completed a Child SCAT-3 evaluation. When the concussed adolescents were grouped by
days’ post-injury, those in the acute phase of recovery scored similarly on the SCAT3 to
those suffering from PCS for both the symptom score (11 ± 6 vs. 10 ± 6; P = 0.62) and
severity score (25 ± 23 vs. 20 ± 20; P = 0.77). Participants’ general anxiety levels over
the 2-week period prior to the initial visit, as measured through the GAD-7, was not
statistically different between the healthy controls and the concussed adolescents.
Furthermore, GAD-7 scores were also not significantly different between the acutely
concussed adolescents and PCS adolescents (5 ± 4 vs. 3 ± 4; P = 0.15). In addition, the
participants’ anxiety at the time of testing, as assessed via the VAS of anxiety, was not
statistically different between the healthy controls and the concussed adolescents (17 ± 13
vs. 16 ± 23; P = 0.34). The VAS of anxiety was developed following the start of the
investigation and was completed in fifteen healthy controls and ten concussed
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adolescents. One participant was on medication for anxiety and was included in the
analysis as results remained the same when the participant was removed from analysis.
Supine hemodynamic parameters, including MABP, systolic BP, diastolic BP,
HR, SV, and CO were not significantly different between the healthy controls and the
concussed adolescents. Compared with the healthy controls, the concussed adolescents
demonstrated reduced TPR in the supine posture (P = 0.02). Furthermore, respiration rate
was higher in the concussed adolescents in the supine posture (P = 0.04). However,
supine PETCO2 was not different between the two groups. Supine PETCO2 was recorded
in a smaller sample of participants that included twelve healthy controls and fourteen
concussed adolescents. There was no difference in supine respirations between the
participants with PETCO2 collected and those without PETCO2 collected in both groups.
Therefore, we can assume that the supine PETCO2 reported is representative of the entire
sample.
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Table 4.1: Participant characteristics and supine hemodynamic and respiratory
parameters.

Values are mean ± SD. CTRL, control; CONC, concussed; BMI, body mass index;
MABP, mean arterial blood pressure; BP, blood pressure; HR, heart rate; SV, stroke
volume; CO, cardiac output; TPR, total peripheral resistance; PETCO2, end tidal carbon
dioxide partial pressure. *Significantly different from CTRL, P ≤ 0.05.
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4.2 Hemodynamic and Respiratory Responses to Standing
The steady-state hemodynamic data for the sitting and standing postures are presented in
Table 4.2. There was a main effect of posture on MABP (P ≤ 0.001), CVR (P = 0.04),
HR (P ≤ 0.001), and PETCO2 (P ≤ 0.001). Compared with the sitting posture, MABP and
PETCO2 were lower in the standing posture while CVR and HR were higher. Sitting and
standing PETCO2 was also collected in a smaller sample of participants including eleven
healthy controls and fourteen concussed adolescents. Further, there was a main effect of
posture on peak CBFV (P ≤ 0.001) and mean CBFV (P ≤ 0.001). Peak and mean CBFV
were lower in the standing posture than in the sitting posture. There was a main effect of
group on respiration (P = 0.02) with the concussed adolescents breathing at a higher
respiration rate than the healthy controls. A posture x group interaction was detected for
SV (P ≤ 0.001) and CO (P = 0.002). Specifically, the concussed adolescents experienced
a larger decrease in SV from the sitting posture to the standing posture. Furthermore, the
concussed adolescents experienced a decrease in CO from the sitting posture to the
standing posture while the healthy controls maintained CO at similar levels between the
two postures. There was no effect of posture or group on TPR.
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Table 4.2: Steady-state hemodynamic and respiratory parameters during sitting and standing postures.

Values are mean ± SD. CTRL, control; CONC, concussed; MABP, mean arterial blood pressure; CBFV, cerebral blood flow velocity;
CVR, cerebrovascular resistance; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance; PETCO2,
end tidal carbon dioxide partial pressure. * Main effect of posture, † Main effect of group, ‡ Posture x group interaction, P ≤ 0.05.
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In contrast to the steady-state data presented above, changes in hemodynamic
parameters during the transition phase between sitting and standing are presented in
Figure 4.1. With standing, MABP drops which elicits a fall in CBFV. The absolute drop
in MABP was statistically similar between the healthy controls and the concussed
adolescents (-24 ± 7 vs. -24 ± 8 mmHg; P = 0.97; Figure 4.1A). The healthy controls
demonstrated an absolute decrease in peak CBFV of 19 ± 8 cm/s and the concussed
adolescents an absolute decrease of 21 ± 4 cm/s (P = 0.45; Figure 4.1B). The absolute
drop in mean CBFV was not statistically different between the healthy controls and the
concussed adolescents (- 8 ± 3 vs. -8 ± 2 cm/s; P = 0.95). Furthermore, the fall in CBFV
produces a reactive reduction in CVR that is also not statistically different between the
healthy controls and the concussed adolescents (-0.5 ± 0.4 vs. -0.4 ± 0.3 mmHg·cm-1·sec1

; P = 0.53; Figure 4.1C). Initially with standing, a small decline in PETCO2 occurs. The

healthy controls demonstrated an absolute fall in PETCO2 of 0.4 ± 0.6 mmHg and the
concussed adolescents an absolute fall of 0.5 ± 1.0 mmHg (P = 0.66; Figure 4.1D). In
addition, a drop in SV occurs with standing that was not significantly different between
the healthy controls and the concussed adolescents (-7.9 ± 20.4 vs. -13.4 ± 15.0 mL; P =
0.24; Figure 4.1G). The decrease in SV was offset by a rapid increase in HR resulting in a
marked initial increase in CO. The healthy controls HR increased by 26 ± 9 bpm and the
concussed adolescents HR increased by 29 ± 7 bpm (P = 0.18; Figure 4.1F). The healthy
controls exhibited an absolute increase in CO of 1.8 ± 0.7 L/min and the concussed
adolescents’ CO increased by 1.5 ± 1.4 L/min (P = 0.34; Figure 4.1E). Finally, a
decrease in TPR occurred in the initial phase of standing that was not statistically
different between the healthy controls and the concussed adolescents (-10.6 ± 4.6 vs. -9.2
± 4.4 mmHg·L-1·min-1; P = 0.27; Figure 4.1H).
The time course of the initial changes in hemodynamic parameters with standing
are presented in Figure 4.2. The healthy controls took 6.2 ± 1.3 seconds to reach nadir
MABP and the concussed adolescents took 6.9 ± 1.1 seconds (P = 0.02; Figure 4.2A).
The time to reach peak MABP was also longer in the concussed adolescents compared
with the healthy controls (15.4 ± 2.6 vs. 14.1 ± 2.3 sec; P = 0.02; Figure 4.2B).
Compared with the healthy controls, the concussed adolescents took longer to reach
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CBFV nadir (4.6 ± 1.9 vs. 5.9 ± 1.4 sec; P = 0.004; Figure 4.2C). However, the time to
reach peak CBFV was not statistically different between the healthy controls and the
concussed adolescents (11.1 ± 1.9 vs. 12.0 ± 1.6 sec; P = 0.07; Figure 4.2D). The time
course of the CVR response was not significantly different between the two groups. With
respect to the time to the initiation of the CVR drop, the healthy controls took 2.5 ± 1.6
seconds and the concussed adolescents took 2.6 ± 1.7 seconds (P = 0.74; Figure 4.2E).
The time to nadir CVR was 8.8 ± 1.7 seconds in the healthy controls and 9.6 ± 1.8
seconds in the concussed adolescents (P = 0.08; Figure 4.2F). Compared with the healthy
controls, the concussed adolescents took longer to reach the peak HR (9.5 ± 1.9 vs. 10.3
± 2.4 sec; P = 0.04; Figure 4.2G). Finally, the healthy controls and the concussed
adolescents did not demonstrate a significant difference in the time to nadir TPR (5.2 ±
1.3 vs. 5.1 ± 1.4 sec; P = 0.72; Figure 4.2H).
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Figure 4.1: Initial hemodynamic and respiratory changes with standing. Values are mean ± SD. CTRL, control; CONC, concussed;
MABP, mean arterial blood pressure; CBFV, cerebral blood flow velocity; CVR, cerebral vascular resistance; PETCO2, end-tidal
carbon dioxide partial pressure; CO, cardiac output; HR, heart rate; SV, stroke volume; TPR, total peripheral resistance. *Significantly
different from CTRL, P ≤ 0.05.
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Figure 4.2: Time course of hemodynamic responses with standing. Values are mean ± SD. CTRL, control; CONC, concussed;
MABP, mean arterial blood pressure; CBFV, cerebral blood flow velocity; CVR, cerebral vascular resistance; HR, heart rate.
*Significantly different from CTRL, P ≤ 0.05.
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4.3 Dynamic Cerebral Autoregulation
The values for RoR calculated from mean CBFV and peak CBFV were not significantly
different for both the concussed adolescents (0.15 ± 0.04 vs. 0.17 ± 0.05 sec-1; P = 0.32)
and the healthy controls (0.21 ± 0.07 vs. 0.22 ± 0.07 sec-1; P = 0.62). Therefore, we
combined the RoR data from the two signal types. The healthy controls RoR was not
statistically different between the first and second visits (0.23 ± 0.08 vs. 0.26 ± 0.13 sec-1;
P = 0.43). Following transient drops in MABP induced by postural adjustments, RoR was
reduced in the concussed adolescents compared with the healthy controls (0.16 ± 0.04 vs.
0.21 ± 0.07 sec-1; P ≤ 0.001; Figure 4.3). In fact, the concussed adolescents demonstrated
a decrease in RoR of 24% from the healthy controls. When the concussed adolescents
were grouped based on day post-injury, there was no difference in RoR between the
acutely concussed and the adolescents with PCS (0.15 ± 0.04 vs. 0.18 ± 0.06, P = 0.22).
Sex differences were not observed in the present investigation with concussed males
exhibiting a RoR of 0.15 sec-1 and females exhibiting a RoR of 0.16 sec-1 (P = 0.75).
Furthermore, a RoR of 0.22 sec-1 and 0.20 sec-1 were witnessed for healthy males and
females, respectively (P = 0.44). Furthermore, analysis showed no correlation between
age and RoR.
A previous history of concussions may influence values of RoR in a subsequent
injury. The healthy controls could be grouped into pure controls who had never sustained
a concussion and controls with a previous history of concussion. There was no difference
in the autoregulatory response between the two groups with the pure controls exhibiting a
RoR of 0.21 sec-1 and the previously concussed controls a RoR of 0.23 sec-1 (P = 0.53).
The concussed adolescents could also be grouped into participants undergoing care for
their first concussion and those with a previous history of concussions. Again, no
differences were witnessed in dynamic CA with both groups demonstrating a RoR of
0.16 sec-1 (P = 0.76).
The current investigation followed the concussed adolescents over the course of their
rehabilitation, for up to 12 weeks. Of the 30 concussed adolescents, 13 participants
provided RoR data for the first and last visits. Furthermore, the participants were either
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medically cleared by their last visit, or rated themselves 100% of baseline, or scored 2 or
fewer symptoms on the SCAT3 symptom evaluation. At the time of the concussed
adolescents last visit, RoR recovered in accordance with clinical symptoms. In fact, no
significant differences were observed between the healthy controls and the concussed
adolescents at their last visit (0.21 ± 0.07 vs. 0.21 ± 0.08 sec-1; P = 0.80; Figure 4.3).

Figure 4.3: Rate of regulation during a sit-to-stand task. Values are mean ± SD. CTRL,
control; CONC, concussed; RoR, rate of regulation. *P ≤ 0.025.

52

Chapter 5

5

Discussion

The main findings of the current investigation are as follows: (1) that adolescents
diagnosed with a concussion demonstrate impaired dynamic CA, indicated by reduced
RoR, and (2) the impairment in dynamic CA recovers in accordance with clinical
symptoms. Therefore, the present data support the hypothesis that adolescent concussion
is marked by impairments in dynamic CA.
The role of head injury on cerebrovascular control has been shown in
experimental models of head-injury (Abdul-Muneer et al., 2013; DeWitt et al., 1992;
Ellison, Erb, Kontos, & Povlishock, 1989; Hayward et al., 2011; Wei, Kontos, Dietrich,
Povlishock, & Ellis, 1981) and in severely-head injured adults (Czosnyka et al., 2001;
Lang et al., 2003; Lee et al., 2001) but its presence in concussion remains uncertain.
Further, studies in humans are normally based on steady-state conditions such as average
blood flow observed in the supine or seated position. Two previous investigations have
evaluated static CA in children and adolescents over a range of TBI severity (Muizelaar
et al., 1989; M. S. Vavilala et al., 2004). Using phenylephrine- or trimethaphan
camsylate-induced changes in ABP both investigations found only variably impaired
static CA in children and adolescents following TBI. However, the use of anesthesia, the
variations in TBI severity, and the age range of participants complicate the interpretation
of these studies. These differences, along with the use of static CA, limits comparison of
the results from the presents study with previous investigations in head-injured
adolescents.
In this study, we addressed the possibility that dynamic, rather than steady-state,
cerebrovascular patterns may expose abnormal cerebrovascular control. Therefore, the
present investigation was the first to describe dynamic CA impairments in adolescents
with a concussion diagnosis. The emphasis on dynamic autoregulatory control in the
current investigation was based on a previous speculation by Tiecks et al. (1995) who
acknowledged that measures of dynamic responses may be of particular importance in
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head-injury, suggesting that the latency of the autoregulatory response is impacted. The
diminished RoR value in the current investigation confirms the speculation by Tiecks et
al. (1995) and suggests that concussion, in some way, impairs the cerebrovascular
response.
Many factors contribute to the cerebrovascular response, including the significant
impact of PaCO2 on vasomotor tone. Levels of PETCO2 at baseline and their change
during the sit-to-stand maneuver could have an effect on the RoR in the concussed
adolescents as states of elevated PETCO2 , or hypercapnia, negatively impacts the RoR in
healthy adults (Aaslid et al., 1989). Furthermore, impairments in cerebrovascular
reactivity to alterations in PETCO2 were reported following head-injury (Becelewski &
Pierzchała, 2002; Enevoldsen & Jensen, 1978; Lee et al., 2001). In the current
investigation, PETCO2 levels were not significantly different between the concussed
adolescents and the healthy controls in the supine, sitting, and standing postures. In
addition, a decline in PETCO2 was witnessed upon standing that was also witnessed in
previous investigations employing a sit-to-stand model (Sorond et al., 2009). However,
the decline was small and was not statistically different between the two groups.
Therefore, it appears that the reduced RoR witnessed in the concussed adolescents could
not be explained by PETCO2 levels. Unfortunately, we were not able to study
cerebrovascular reactivity to CO2 in these patients due to potential symptom exacerbation
with administration of a CO2 gas mixture.
An additional factor that could influence the cerebrovascular response is the
astrocyte-vascular interactions. Normally, astrocytes play a critical role in linking
neuronal metabolic activity with the local vascular response (Iadecola, 2004). Recently,
Augustine et al. (2014) used an endothelial cell-astrocyte co-culture to examine the
effects of simulated blast injury on the coupling of these two tissues. Following the air
blast, the astrocytic end-feet moved away from the vasculature which could compromise
neurovascular coupling and lead to impaired vascular responses (Augustine, Cepinskas,
Fraser, & Group, 2014). Recently, an investigation reported the involvement of astrocytes
in pressure and flow evoked changes in vasomotor tone (Kim et al., 2015). This
observation supports the findings from Augustine et al. (2014) that retraction of the
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astrocytes may impair the cerebrovascular response particularly during changes in
pressure and flow. However, relating the cell culture model employed in the study by
Augustine et al. (2014) to human concussion must be considered carefully as concussions
are a mild form of injury whereas the air blast to the cell culture may be more
representative of severe forms of TBI. In fact, data from the present investigation
suggests the cerebrovascular response was not compromised in adolescent concussion.
With standing, the initial reduction in CVR was not statistically different between the
concussed adolescents and the healthy controls. This observation opposes the
investigation conducted by Bailey et al. (2014) which reported a larger relative reduction
in CVR in the TBI patients compared with the healthy controls. One likely reason for this
difference is that the current investigation evaluated primarily acutely concussed patients
while the study by Bailey and colleagues (2013) evaluated chronic TBI patients who
experience repetitive sub-concussive head-impacts. Thus, these two populations differ
significantly in the severity of the injury and would likely exhibit varying levels of CA
impairment. In fact, the current investigation showed a 24% reduction in RoR between
the healthy controls and concussed adolescents while the boxers demonstrated a 48%
reduction in RoR from the healthy controls. In addition, the time course of the changes in
CVR in the present investigation further demonstrate intact vascular responses. The
healthy controls and concussed adolescents showed no significant difference in the time
to the initiation of the CVR drop or in the time to the nadir CVR suggesting the
cerebrovascular response does not appear to be compromised at least in the concussion
spectrum of disorders. Therefore, we must consider additional factors that could
contribute to RoR including central hemodynamic responses.
Central hemodynamics could influence the RoR through variations in the
components of the RoR calculation or in the rate of the underlying physiologic responses
(Figure 5.1). In the current investigation, the initial absolute drop in MABP was
statistically similar between the concussed adolescents and the healthy controls. This is
consistent with a previous report employing the thigh-cuff model in TBI patients and
healthy controls (Bailey et al., 2013). However, Jünger et al. (1997) found the MABP
drop to be of smaller magnitude in mild TBI patients compared with the healthy controls.
The inconsistent results between the current study and that of Jünger et al. (1997) may be
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due to the use of the thigh-cuff model which results in highly variable drops in ABP with
each trial (Sorond et al., 2009). The drop in MABP observed in the current investigation
is similar to previous investigations using sit-to-stand models for the evaluation of
dynamic CA (Lipsitz et al., 2000; Sorond et al., 2009). However, in assessing the time
course of the MABP response in the present investigation, the concussed adolescents
took longer, by approximately 10%, to reach nadir MABP when compared with the
healthy controls. A group effect also emerged in the time course of the HR response with
the concussed adolescents taking longer, by approximately 8%, to reach peak HR
compared with the healthy controls. The HR response may be prolonged in the concussed
adolescents due to dysregulation in autonomic function. The increase in HR with
standing has been attributed to rapid vagal withdrawal (Ewing et al., 1980). In fact, it has
been reported that concussion is marked by cardiac autonomic dysregulation, specifically
measures of vagal activity (Gall, Parkhouse, & Goodman, 2004; Su, Kuo, Kuo, Lai, &
Chen, 2005). In as much as the HR response influences the duration of the drop in MABP
with standing, the impaired neural control of HR may translate into cerebrovascular
dynamics. Therefore, the present observations suggest that sluggish central
hemodynamics may contribute to the reduced RoR in the concussed adolescents. It is
noted, however, that duration of the fall in CBFV with standing was approximately 28%
longer in the concussed adolescents and does not appear to be accounted for completely
by the slower central hemodynamics. Therefore, while these data point to the integrative
nature of studying CBF control, more studies are needed to understand, for example, the
interactions between the neural control of HR and cerebrovascular autoregulation.

Figure 5.1: Schematic of the rate of regulation calculation and potential contributors to
cerebral autoregulation.
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As mentioned, the present investigation was the first to employ dynamic measures
of CA in concussed adolescents. One previous investigation has studied dynamic CA in
healthy adolescents using the thigh-cuff method and witnessed lower dynamic ARI
values in the adolescents compared with the healthy adults (M. Vavilala et al., 2002).
This finding was not replicated in a later study which demonstrated similar static ARI
values between children and adults under general anesthesia (M. Vavilala et al., 2003).
From these findings, it appears that age may play a role in dynamic CA while static CA is
seemingly unaffected by age. However, observations from the present investigation
provides evidence that RoR, analogous to dynamic ARI, is similar between adolescent
and adult populations. The values observed for the healthy controls in the current
investigation are in line with the values reported by Aaslid and colleagues (1989) in
healthy adults. Specifically, the healthy adolescents in the current investigation
demonstrated a RoR of 0.21 sec-1 whereas the healthy adults in the study by Aaslid and
colleagues (1989) exhibited a RoR of 0.20 sec-1. Furthermore, using the thigh-cuff
method, Bailey et al. (2013) demonstrated absolute values of RoR in adults following
head-injury that are almost identical with the concussed adolescents in the current
investigation (0.18 vs. 0.16 sec-1). Therefore, indices of autoregulation, both static and
dynamic, are shown to be similar across a range of ages.
We must acknowledge that different models were utilized to induce a drop in
ABP between the current investigation and the investigations conducted by Aaslid et al.
(1989) and Bailey et al. (2013). In the previous investigations, the thigh-cuff model was
employed to produce a rapid, transient drop in ABP (Aaslid et al., 1989; Bailey et al.,
2013). However, due to the high number of trials that are required and the painful nature
of the test (Sorond et al., 2009), it is not a suitable protocol to employ in a young
population with concussion. Therefore, we opted to use a sit-to-stand model as it has
provided similar results to the thigh-cuff model and is a more tolerable test (Sorond et al.,
2009). Sorond and colleagues (2009) performed both the sit-to-stand and thigh-cuff
deflation tests in a group of healthy participants. The two models produced similar
absolute drops in ABP and CBFV although slower declines were seen in both parameters
in the sit-to-stand model (Sorond et al., 2009). A slightly larger drop in PETCO2 was
witnessed in the sit-to-stand model (Sorond et al., 2009). However, at the time of CBFV
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nadir, the drop in PETCO2 was similar between the two models so it was proposed that
CA would likely not differ significantly between the two models (Sorond et al., 2009). In
fact, Sorond and colleagues (2009) found similar dynamic ARI values with both models.
The sit-to-stand model was also associated with a higher between-subjects’ variability but
lower within-subject variability and a higher intraclass correlation coefficient (Sorond et
al., 2009). Therefore, the sit-to-stand model is a reliable alternative to the thigh-cuff
model.
The current investigation was also the first to describe the temporal resolution of
dynamic CA throughout clinical recovery in concussed adolescents. A few studies have
investigated temporal resolution of CA in adults suffering from moderate to severe TBI
(Lang et al., 2003; Lee et al., 2001). These investigations witnessed an impairment in CA
that began improving between four and six days’ post-injury (Lang et al., 2003; Lee et
al., 2001). Recovery has been shown to vary significantly between adults and adolescents
limiting the comparison of the results from the present study to the investigations of
temporal resolution in adults (Field et al., 2003; Lovell et al., 2003; Pellman et al., 2006).
Nonetheless, the observation that the impairment in dynamic CA recovered with
symptom improvement suggests that this measure reflects injury status.

5.1 Limitations
This investigation does involve various methodological considerations and limitations
that must be acknowledged. First, the use of TCD only permits the estimation of CBF
from measures of CBFV (Clark et al., 1996; Lindegaard et al., 1987; Newell et al., 1994;
Valdueza et al., 1997). True quantification of CBF requires a measure of CBFV and
vessel CSA (Kontos, 1989). However, previous investigations have provided evidence
for stable vessel CSA in the face of altered ABP proving the validity of TCD to quantify
CBF (Aaslid et al., 1989; Aaslid et al., 1991; Giller et al., 1993; Larsen et al., 1994;
Lindegaard et al., 1987; Newell et al., 1994; Serrador et al., 2000).
We must also take into consideration the adolescent population studied in the
current investigation and acknowledge the ongoing maturation that occurs in this
population. Previous research has demonstrated alterations in cerebral hemodynamics
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with age (Biagi et al., 2007; Hales, Kawadler, Aylett, Kirkham, & Clark, 2014; Leung,
Kosinski, Croal, & Kassner, 2016). However, regression analysis showed no significant
correlation between age and RoR in the present investigation. Furthermore, it has been
previously reported that static ARI values are similar between children and adults (M.
Vavilala et al., 2003) and the data from the current investigation support this finding with
similar RoR values witnessed between the adolescents from the present study and adults
from previous investigations (Aaslid et al., 1989; Bailey et al., 2013). Nonetheless, it is
important to consider the factor of age and development in studies of cerebral
autoregulation in the adolescent population.

5.2 Conclusion and Impact
This study was the first to demonstrate impaired dynamic CA in adolescents diagnosed
with a concussion. This finding has significant impact on characterizing the physiological
changes that occur with adolescent concussion. Specifically, it is of major importance to
understand the cerebrovascular outcomes of concussion to help guide concussion
rehabilitation and management. The present investigation also demonstrated that the
impaired dynamic CA recovers in accordance with clinical symptoms. Therefore, RoR
appears to be an objective marker that scales to the injury. Dynamic CA may provide a
useful clinical tool that can ensure accurate diagnosis, guide rehabilitation, and aid in
decisions regarding patient’s readiness to return to sport.
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STUDY TITLE: Investigating novel treatments for concussion: Impact of
compression vest on rehabilitation outcomes.
The Principal Investigators: Kevin Shoemaker, Ph.D.
Co-Investigators: Dr. Douglas Fraser, MD, PhD, FRCPC
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Tim Doherty, MD
Jeff Holmes, Ph.D.
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Introduction:
The pronouns “you” and “your” in the letter should be read as referring to the participant
rather than the legal representative who may be signing the consent form. If you are a
substitute decision maker (i.e. someone who makes the decision about participation on
behalf of a study participant) please remember that “you” refers to the study participant.
You are being asked to voluntarily take part in a research study. We are asking you or
your substitute decision maker to give your consent (sign and date) separately to each of
the following three procedures. Before you decide, read all the details about the purpose,
procedures, risks, benefits, discomforts and precautions of this study. You should take as
much time as you need to make your decision. This form may contain words or details
that you do not understand. Please ask the study staff to explain anything that you do not
understand and make sure that all of your questions are answered. Feel free to talk about
this study with anyone you wish. If all of your questions have been answered to your
satisfaction, and you decide to take part of this study, you will be asked to sign the
consent form and upon your request you will receive a copy of this letter of information
and consent form to keep.
Background and Purpose:
The purposes of this research are 1) to determine the impact of wearing a compression
vest (a tight fitting vest or shirt) on the symptoms related to your concussion, 2) to see
how symptoms of your concussion relate to the control of your heart rate, and 3) to see if
physical exercise improves your concussion. To complete the study we will be recruiting
approximately 120 concussed patients and 85 non-concussed age-matched, healthy
individuals.
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Inclusion: To be included in the study you will be 12-40 years of age with a medical
diagnosis of, and being treated for, a concussion with symptoms that have lasted less
than one year. This study will also be completed by 85 individuals with no concussion
(healthy, age-matched controls) to quantify age specific normative values. Adolescents
(aged 12-18 yrs) and adults (aged 19-40 years) will be studied as separate groups.
Exclusion: You will not be included in the study if you have any of the following
concerns:
- Bone or muscle problems that could impact balance or how well you walk,
- Diagnosis of pre-existing heart disease,
- Medications that affect heart or blood vessel control
- Pre-existing brain disorders such as Parkinson’s, Multiple sclerosis, Raynaud’s,
Multiple System Atrophy, metabolic disorders such as diabetes, a history of
significant neck injury, disease or surgery, Rheumatoid arthritis, vertebral basilar
artery insufficiency, or focal neurologic deficit
- Primary or metastatic bone tumor,
- Severe osteoporosis,
- If you are, or think you might be, pregnant or are breastfeeding
- You are not able to understand English,
Procedures:
Outline of the study:
You will be tested once a week, over a 6 week time period for a total of 6 testing
sessions. Testing sessions 1 and 2 will occur before your rehabilitation begins. The 3rd,
4th 5th and 6th test session will occur over 4 weeks of rehabilitation, unless you are
asymptomatic and discharged from the clinic. See Figure 1 for a flow diagram of the
study.
Testing session 1: Upon diagnosis with a concussion, you will be invited to participate in
this study. If you consent to participate you will be randomized to either the compression
vest or no compression vest condition and will complete a series of clinical and research
tests (balance, anxiety/depression questionnaire, cardiovascular, exercise tolerance and
cognitive evaluations).
Testing session 2: You will be required to come back to the clinic 1-2 weeks after testing
session #1. The same clinical and research tests conducted during testing session 1, will
be conducted throughout testing session 2. If on day #1 you were randomized to the
compression vest group you will wear the vest again. If you were randomized to the no
vest group, you will not wear a compression vest. If the physician determines that you are
asymptomatic then you will exit the study. However, if you are symptomatic and willing
to continue with the study, you will begin the 4-week rehabilitation program. For the 4week rehabilitation program you will be randomized into one of three groups:
1) Exercise + Vest: Exercise three times per week with one session occurring during
your physiotherapy clinic visit and the two other sessions on your own at home.
You will be instructed about how hard you are to exercise and when to wear the

80

compression vest. If your symptoms become worse during any exercise session
you are to stop that session and rest. You are asked to keep a record of your
exercise and any symptoms or emotions you feel. A log book will be provided.
2) Exercise - No Vest: Exercise three times per week with one session occurring
during your physiotherapy clinic visit and the two other sessions on your own at
home. You will be instructed about how hard you are to exercise. If your
symptoms become worse during any exercise session you are to stop that session
and rest. You are asked to keep a record of your exercise and any symptoms you
feel. A log book will be provided.
3) Rehabilitation Control: This is the current clinical management protocol. You will
be provided 4 physiotherapy appointments (one per week) but you will not be
completing a prescribed exercise program. You are asked to keep a record of your
exercise activities outside of the clinic appointment as well as any symptoms you
feel. A logbook will be provided.
Testing Session 3-5: You will come to the clinic for your physiotherapy appointment as
well as complete a series of clinical and research tests (balance, anxiety/depression
questionnaire, cardiovascular and cognitive evaluations, exercise tolerance test). Testing
should take ~60 minutes in addition to your physiotherapy appointment.
Testing Session 6: You will come to the clinic to complete a series of clinical and
research tests (balance, anxiety/depression questionnaire, cardiovascular and cognitive
evaluations, and exercise tolerance test). Testing should take ~60-80 minutes. You will
then exit the study.
*At all testing sessions, you will be asked to give up to 1-15 ml venous blood sample.

Study Flow Diagram
Detailed Procedures:
NOTE: the tests outlined below will take place at either the Fowler Kennedy Sports
Medicine Clinic (adolescent and adult groups) or the Parkwood Hospital outpatient
rehabilitation clinic (adults only), depending on where your treatment is being performed.
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By signing the consent form, you are giving your permission for the research team to
obtain your complete medical history and imaging, and neuropsychological tests from
other hospitals, clinics and imaging facilities.
Concussion Questionnaires and Clinical Data: You will be asked to fill out a brief
questionnaire about your levels of anxiety or stress.
Exercise Tolerance Test: Briefly, you will complete an endurance exercise protocol,
either on a treadmill or cycle ergometer. Initially the workload will be very low, but will
progressively increase each ensuing minute until: 1) you become too exhausted to
continue 2) your symptoms become too strong to continue 3) maximal speed or incline on
the treadmill/cycle ergometer is achieved. Every minute your heart rate (HR), symptoms
(visual analog scale 1-10) and rating of perceived exertion (20 point Borg scale) will be
evaluated. If the maximum incline is achieved before symptom onset or before you
become too fatigued to continue then the speed will be increased by 0.4 mph each minute
until you can no longer continue. HR and RPE at the cessation of exercise) will be
documented and used to determine your individualized exercise program. The exercise
tolerance test will be conducted up to 6 times during your enrollment in this investigation
(one exercise tolerance test per visit).
Brain Blood Flow Study: Using a head strap, a small probe that emits ultrasound waves
(transcranial Doppler ultrasound) will be held against your head just behind your eye.
This probe will assess changes in blood flow to your brain. Finger blood pressure and the
electrocardiogram will also be measured. Measures will be made while you sit quietly on
a chair and then while you move between the seated and upright positions (unassisted
standing and sitting) in two-minute increments (3 minutes seated, 2 minutes quiet
standing). This will be repeated up to five times and stopped if symptoms get worse.
These studies will be performed in Neurovascular Research Laboratory, Room 3110
Thames Hall (an elevator ride and ~20 metre walk from the Fowler Kennedy Sports
Medicine Clinic).
Balance Testing:
Patients will have their balance assessed using one or more of the following tests:
1) Modified Clinical Sensory of Integration and Balance Test: This test involves
measuring your balance with your eyes open and closed while standing on either a
firm surface or on a foam surface. You may be asked to stand on two feet, on one
foot. The tasks involved will take up to 10 minutes to complete.
2) “HUR” balance assessment: This test requires you to maintain your balance while
completing a series of maze and star-like patterns on the HUR platform. The tasks
involved will take up to 10 minutes to complete.
Vestibular Oculomotor Study: This test is to see how your eyes affect your balance. This
is a standard physical therapy test called the “Vestibular Ocular Motor Screen” (VOMS).
If you are receiving treatment at Parkwood Hospital, you may also be asked to participate
in another standard procedure to improve your vision, called the “Binocular Vision
Assessment” (BVA) (approximately 20 minutes)
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Neurofunction: In addition to the normal clinical diagnostic questionnaires (e.g.,
SCAT3), you are asked to complete the Generalized Anxiety Disorder Questionnaire 7
(GAD-7) and the Cognigram. The Cognigram is an online cognitive task, which
evaluates different aspects of cognition. The test consists of 4 different playing-card
tasks, in which you are instructed to answer as quickly and accurately as possible. Before
testing, one of the research assistants will provide you with instructions. The tasks
involved will take up to 10 minutes to complete.
Heart Rate and Blood Pressure Monitoring: During your standard treatment your heart
rate (the electrocardiogram), finger blood pressure (Finometer device) and breathing
patterns (a loose strap around your chest) will be measured. These will be made during 510 min of rest and also during each of your therapist’s treatments when possible such as
during a neck treatment or balance testing, as well as during the sit-and-stand test, and
exercise.
Compression Vest: In some cases, the measurements and tests outlined above will
performed while you wear a compression vest around your chest. In some cases, this vest
will include sensors that can measure your electrocardiogram (from your heart), how you
breathe, and how you move. You may be asked to wear this vest at home along with
instructions about how to record the data using the small device attached to the vest. You
will then return the shirt and data device on your next clinic visit. See Figure 2 below.

Compression Vest © Parkwood Hospital
Exercise Training: You are asked to perform endurance exercise (cycling, running) for 20
minutes at each session. The intensity of this exercise will be determined first by your
therapist but you will be able to adjust the intensity as needed to a level just below that
which causes your symptoms to increase, or as directed by your therapist. You will
perform this exercise once in the clinic at your weekly appointment, and then two more
times during the week at home. You will be requested to maintain a brief log book
documenting this exercise, additional activities and how you feel (anxiety, fatigue level
etc.) throughout each day. You will receive instructions on how to exercise at home.
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Sleep Analysis: The Groningen Sleep Quality Scale (GSQS) will be included in your
exercise training log book (described above under exercise training). While enrolled in
the study you will be asked to rate the quality of 2-3 sleeps per week. The GSQS consists
of 15 true/false questions and should take no longer than 5 minutes to complete.
Blood Analysis: We would like to take 1-15ml blood sample from you at each of the 6
proposed days of clinical assessment (diagnosis, 2-week, 3-week, 4-week, 5-week and 6week post diagnosis). Blood samples will be drawn by either physicians at Fowler
Kennedy or by members of the research team who certified in phlebotomy. You will be
sitting comfortably in a chair with an armrest for the specimen collection. Prior to the
blood drawn you will be thoroughly briefed on procedure. Furthermore you will be
provided blankets, pillows, food and drink if in the event you react negatively.
Risks/Discomforts/Inconvenience:
Questionnaires: There are no known risks with the questionnaires. In the event of
exacerbated post-concussion symptoms, all testing will be stopped immediately and
resumed again only after a minimum period of 24 hours of rest until your symptoms
return to normal.
Exercise Tolerance Test: The end of the exercise test will be determined by when your
symptoms are more than 3 points above baseline symptom scores (symptoms rated on a 010 visual analog scale). If they do not get worse, the test will stop when you are too tired to
continue. The test may make you tired for a few hours. There is a 1/1000 - 1/10,000
chance of major complications such as heart attack, myocardial ischemia, stroke or death
during vigorous exercise. Being older or having a pre-existing heart condition can
increase the risk. You will be watched by a medical physician or your physical therapist
and the test will be stopped immediately when you report a change in your concussion
symptoms or you feel too tired to continue, whichever comes first.
Electrocardiogram: The adhesive on the electrodes used to measure your heart rate may
cause a small rash to develop under the electrode. However, this rash should disappear in
a day or two.
Blood pressure cuff: There are no known risks of using the finger cuff methods
(Finometer) of examining arterial blood pressure. With the finger cuff the fingertip may
turn a little blue and feel numb during the prolonged test sessions but this resolves
immediately when the cuff is removed. Standard arm cuff blood pressure measures of
arterial pressure will also be obtained periodically, a method that has no known risks.
Brain Blood Flow: There are no known risks associated with transcranial Doppler
ultrasound. There is a small risk that you may experience a temporary loss of balance. A
personal support staff member will minimize this risk.
Balance: These tests are part of normal clinical treatment, and will be performed in the
clinical setting providing immediate medical support and knowledgeable testing
environment. There is a small risk that you may experience a temporary loss of balance
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during the completion of tasks used to assess their balance and gait. This risk is
anticipated to be no greater than that which the patients would normally experience
performing routine activities over the course of a day. Hand rails and/or a personal
support staff member will minimize this risk. Tests will be stopped if concussion-related
symptoms are exacerbated.
Cognitive Function Analysis: There are no known risks associated with the Cognigram
evaluation. However, if the computer screen exacerbates your symptoms you will be
instructed to stop testing immediately.
Blood Analysis: There is risk of infection or cross-contamination when venous blood
samples are drawn. Therefore, either the physician, registered nurse of trained
phlebotomist, will employ sterile blood handling techniques and take into account all
preventive measures to ensure you are not exposed to any additional risks.
Your Rights:
Participation in this study is voluntary. You may refuse to participate, refuse to answer
any questions or withdraw from the study at any time with no consequences.
Benefits to Being in the Study:
You may or may not receive any direct benefit from being in this study. If you sustain a
concussion during the study period, you will receive direct referral to Fowler-Kennedy
Sports Medicine Clinical for assessment. Information learned from this study may help
other people with concussions in the future.
Withdrawal:
You can withdraw from any or all parts of this study at any time with no consequences.
Questions:
If you have any questions or concerns about the study, you can contact Dr. Kevin
Shoemaker (519-661-2111 x85759).
If you have any questions about your rights as a research participant or have concerns
about this study, you may contact Dr. David Hill, Scientific Director, Lawson Health
Research Institute, at 519-667-6649.
Conflict of Interest:
The Children’s Health Foundation represents the funding source of this study. The
Clinics and Institutions involved in this study all have an interest in completing this
study. Their interests should not influence your decision to participate in this study. You
should not feel pressured to join this study.
Confidentiality:
If you agree to join this study, your medical information collected during the study will
be kept confidential by the study staff and will not be made available unless disclosure is
required by law. Following collection, all information collected during this study will be
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assigned a number and then entered into a secure electronic database at the institution,
along with the subject identification code assigned to each subject. Therefore, the data
cannot be linked to you. The data collected will be available to principal investigator and
researchers involved in the study, whereas encrypted personal identification (name, date
of birth) will be restricted to only to small number of authorized research staff. You will
not be named in any reports, publications, or presentations that may come from this
study. If you decide to leave the study, the information about you that was collected
before you left the study will still be used. No new information will be collected without
your permission.
Please be aware that Representatives of the Western University Health Sciences Research
Ethics Board and/or Lawson Quality Assurance Education Program may contact you or
may require access to your study related records to monitor the conduct of the research.
Compensation:
If you are in the Adolescent age category and treated at Fowler Kennedy Sports Medicine
Centre, up to four physiotherapy rehabilitation visits will be provided free of charge.
Otherwise, you will receive no compensation for your participation in any parts of this
research except for reimbursement of the parking up to a maximum of $50.
Consequences of getting ill or harmed during the study:
If you become ill, injured or harmed as a result of the investigations in this study, you
will receive care. The reasonable costs of such care will be covered for any injury, illness
or harm that is directly a result of the investigations this study. By signing the consent
form, you do not waive your legal rights nor release the investigators, sponsors or
involved institutions from their legal and professional responsibilities.
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LETTER OF INFORMATION
Study Title: Investigating novel treatments for concussion: Impact of compression
vest on rehabilitation outcomes.
Consent
I have read the letter of information, have had the nature of the study explained to me and
I agree to participate. All questions have been answered to my satisfaction.
I consent to do the following procedures:
___ Concussion questionnaires/survey/clinical examination
___ Exercise Test
___ Exercise Intervention
___ Sleep Analysis
___ Cognigram (Cognitive Evaluation)
___ Brain Blood Flow Test
___ Balance Test
___ Vestibular Oculomotor Study
___ Venous Blood sample
Print Study Participant’s Name

__________
Date

Signature

(You will be given a signed copy of this consent form)
Your signature means that you have explained the study to the participant named above.
You have answered all questions.
Print Name of Person Obtaining Consent

__________
Date

Signature

Was the participant assisted during the consent process?

YES

NO

If YES, please check the relevant box and complete the signature space below:
The person signing below acted as a translator for the participant during the consent
process and attests that the study as set out in this form was accurately translated and has
had any questions answered.
Print Name of Translator

Signature

Relationship to Participant

Language

____________
Date
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The consent form was read to the participant. The person signing below attests that
the study as set out in this form was explained accurately, and has had any questions
answered.
Print Name of Witness

Signature

____________
Date

Relationship to Participant
Consent in the event a substitute decision maker is applicable:
This study and its purpose have been explained to me as well as the participant named
above. I have been given the chance to ask questions and to discuss the participant’s
participation in this research database with the study doctor. I have been told that study
participation can be ended at any time. As the Substitute Decision Maker for this
participant, I hereby give consent for this participant to participate in this research
database. I conclude that the participant wishes to participate in this research and has
indicated his/her assent to do so. I will give a copy of this signed and dated document to
the participant and will be given a copy as well.
___________________________________
Name of Substitute Decision Maker (Print)
___________________________________
Signature of Substitute Decision Maker

______________________
Date

___________________________________
Signature of Person Obtaining Consent

______________________
Date
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LETTER OF INFORMATION
TITLE: Cerebrovascular and autonomic function outcomes in adolescents diagnosed with a
concussion
Principal Investigator: Kevin Shoemaker, PhD
Co-Investigators: Douglas Fraser MD, PhD; Lisa Fischer, MD; John McCuaig, MD;
Arlene Fleischhauer, RN; Erin Moir, BA; Alexandra Harriss, MSc
Funding Source: The Children’s Health Foundation
INTRODUCTION AND PURPOSE
The pronouns “you” and “your” in the letter should be read as referring to the participant rather than
the legal representative who may be signing the consent form. If you are a substitute decision
maker (ie. someone who makes the decision about participation on behalf of a study participant)
please remember that “you” refers to the study participant.
Since you have been diagnosed with a concussion, you are being invited to
participate in a research study that will examine the health and function of your heart
and brain blood flow. We are particularly interested in how a concussion affects brain
blood flow when you move from lying down, to sitting upright and then to standing. The
study will consist of up to six testing sessions in our lab. Each of these testing
sessions may occur before or after your appointment with a concussion physician at
Fowler Kennedy Sport Medicine Clinic (FKSMC). Each laboratory testing session will
last anywhere from 1.5 to 2.0 hours. A total of 160 participants will be recruited for this
study. Before agreeing to participate, please read this LETTER OF INFORMATION
and ask any questions you wish.
PARTICIPANT INCLUSION/EXCLUSION CRITERIA
This study will include a group of healthy ‘control’ participants as well as a group who
has been diagnosed with a concussion, and are still experiencing symptoms from their
concussive injury.
Inclusion Criteria: To be included in this investigation you must be between 12-18
years of age and have been diagnosed with a concussion by a physician at Fowler
Kennedy Sport Medicine Clinic (FKSMC) or already diagnosed and subsequently
referred to FKSMC for further evaluation.
Exclusion Criteria: You will not be included in the study if you have any of the following:
pre-existing heart disease, currently taking medications that could affect heart or blood
vessel control, significant respiratory disease/illness (such as, but not limited to, COPD,
cystic fibrosis), pre-existing neurological disorder (such as, but not limited to Parkinson’s,
multiple sclerosis, or multiple system atrophy), bone or muscle problems that could
impact balance or gait, major psychiatric condition, unable to provide written informed
consent, complete questionnaires or health history forms due to language or cognitive
difficulties. Lastly, you will not be included in the study if you are, or think you might be,
pregnant.
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STUDY DESIGN and PROCEDURE
If you agree to participate in this research program, you will be asked to come to the
laboratory for up to 6 testing sessions. Testing sessions will be conducted for up to 12
weeks. Your enrollment in the study will end either after 12 weeks of testing or when you
are discharged from clinical care by your physician at FKSMC (whichever comes first).
Tests: Each testing session will last between 1.5 and 2.0 hours and will be conducted in the
Neurovascular Research Laboratory, Thames Hall Rm 3110 at Western University. Here is a
sample of the tests you will be asked to perform on each day (the order of testing may vary
depending on schedules):
Sample Laboratory Testing Day – Flow Diagram:

EXPERIMENTAL MEASURES: Listed below is a description of each experimental measure
used in these studies. These are in addition to the measures made by the staff at FKSMC (but
may be a repeated measurement). *Note – by signing the consent form, you are giving your
permission for the research team to view information from your medical history, which is relevant
to this investigation.
Sport Concussion Assessment Tool (SCAT): A standardized paper and pencil questionnaire
designed to evaluate your concussion rehabilitation. The questionnaire will take up to 10 minutes
to complete and will evaluate of i) your symptoms, ii) how well you can remember or think, iii) your
balance, and iv) your muscle coordination.
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Anxiety Questionnaire: Two paper and pencil measures of anxiety are included: The GAD-7
evaluates your anxiety over the last week. The Visual Analog Scale evaluates your anxiety at that
specific moment in time. Both questionnaires will take up to 5 minutes to complete.
Tanner Scale: For this questionnaire you will circle the images which best reflect your current
body status. You will be provided the option to complete this scale either with or without your
parents in the room. You are allowed to skip any questions that you do not want to answer.
Blood Sample: After resting quietly for up to 30 minutes, a blood sample will be taken from a vein
near your elbow. The total volume of the blood sample will not exceed 6-10 table spoons (40mL).
Blood samples will be drawn by either physicians/nurses at Fowler Kennedy or by trained members
of the research team. For the blood draw you will be either laying down or sitting comfortably in a
chair with an armrest. Blankets, pillows, food and drink will be available in the event you react
negatively.
Cardiovascular Monitoring: Throughout the testing procedure your heart rate (standard 3-lead
electrocardiogram), blood pressure (a small cuff placed on your finger and a larger cuff around
your upper arm) and breathing patterns (an elastic band placed around your chest) will be
measured.
End Tidal CO2 Gas Collection: Throughout the testing procedure you will wear a facemask that
straps to the back of your head and covers your nose and mouth. This mask will allow us to
measure gases in your breath.
Transcranial Ultrasound: Using a headband, a small probe will be held just against your skin
just behind your eyes. This probe emits ultrasound waves and is used to measure blood flow to
your brain.
Submaximal Hand Grip: Using a plastic hand grip device you will complete up to 5 handgrip
contractions at efforts that are no more than 50% of your maximal strength. Each contraction will
last no more than 30 sec and you will be able to rest for about 60 seconds between each
contraction.
Sit-to-stand test: For this task you will sit quietly in a chair for up to 3 minutes, stand for 2
minutes, and then sit again. This protocol will be repeated 12 times under 4 different conditions
(listed below). The 4 conditions will alter your end tidal CO2 (the concentration of carbon dioxide
that you breathe out). Carbon dioxide is produced by your body and affects the blood flow in
your brain. The conditions are as follows:
1) Spontaneous normal breathing (~35 mmHg end tidal CO2)
2) Hypocapnia: You will be breathe a little faster than normal using a metronome. This will
reduce the carbon dioxide levels in your exhaled air to about 25 mmHg.
3) Normocapnia: You will continue breathing a little faster than normal (to the metronome).
This time a small amount of carbon dioxide will be added to the air you breathe to keep your
body levels of carbon dioxide the same as in condition 1 above.
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4) Hypercapnia: You will continue breathing a little faster than normal (to the metronome). This time
an amount of carbon dioxide will be added to the air you breathe to keep your body levels of
carbon dioxide a little higher than normal (~40 mmHg end tidal CO2)
STUDY BENEFITS
There is the possibility that you will receive no personal benefit from this study. However, your
participation may benefit society as information learned from this study may help advance
concussion diagnoses and rehabilitation in the future.
STUDY RISKS
Venous Blood Sample: There is a small risk of bruising or infection when collecting blood from your
vein. Some people may experience mild pain and discomfort and some may feel nauseous, dizzy or
faint when blood is taken. To avoid this, we will be collecting blood from you while you are lying
down.
Electrocardiogram: The adhesive on the electrodes used to measure your heart rate may lead to
temporary redness of the skin on your chest.
Blood Flow/Pressure Measures: There are no known harmful effects with the measures of blood
vessels or blood flow using ultrasound imaging, or blood pressure, as used in this study.
Questionnaires/ health evaluations: There are no risks with the questionnaires
Sit-to-stand test: You may feel a little dizzy or light-headed upon standing. The test will be
stopped if you feel unwell.
CO2 gas mixture: Breathing a slightly higher level of carbon dioxide may give you a small
headache and it may make you feel breathless. These feelings vanish quickly when you start
breathing room air again.
Hand Grip: There are no known adverse effects of completing repeated 30s submaximal
handgrip contractions. However, if symptoms are exacerbated participants will be instructed to
stop the procedure immediately
YOUR PARTICIPATION
Participation in this study is voluntary. You may refuse to participate, refuse to answer any
questions or withdraw from the study at any time with no effect on your future care, academic
status, or employment.
The blood specimens will be discarded or destroyed once they have been used for the purposes
described in the protocol.
If you are participating in another study at this time, please inform the study coordinator
right away to determine if it is appropriate for you to participate in this study.
Whether you agree to participate in this study or not, you will be asked if you consent to having
your name and contact information added to a master database of individuals who would be
willing to be contacted in the future regarding your interest in other research studies.
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Representatives of the Western University Health Sciences Research Ethics Board may
contact you or require access to your study-related records to monitor the conduct of the
research.
CONFIDENTIALITY
Your research records will be stored for up to 15 years in a secure office at Western
University. To further protect your confidentiality, your name will be replaced with a subject ID
number on all documents. The master list linking your identity and subject ID number and
your contact information will be stored separately in a secure office at Western University.
Your contact information will be securely maintained at Western University to allow for setting
up follow up visits. If the results of the study are published, your name will not be used and no
information that discloses your identity will be released or published. No information that could
reveal your identity will be released to anyone. If you decide to leave the study, the
information about you that was collected before you left the study will be deleted upon your
request.
If we find information we are required by law to disclose, we cannot guarantee confidentiality.
Please be aware that Representatives of the Western University Health Sciences Research Ethics
Board and/or Lawson Quality Assurance Education Program may contact you or may require
access to your study related records to monitor the conduct of the research.
ALTERNATIVES TO STUDY PARTICIPATION
You may choose not to participate in this study.
REIMBURSEMENT
You will be reimbursed for parking/public transit costs up to $50 for your participation in this
investigation ($5/per visit). Additionally, to offset the costs of travel and treatments, you will receive
up to four free physiotherapy appointments at FKSMC – UWO location (at no cost to you).
CONTACT PERSONS
If you have any questions about the study please contact:
Concussion Research Staff: Alexandra Harriss (519) 661-2111 ext 88526
Research Nurse: Arlene Fleischhauer (519) 661-2111 ext 88085
Principal Investigator: Dr. Kevin Shoemaker (519) 661-2111 ext 85759
Or send an email to lbhhuwo@uwo.ca
Please note that email is not considered a secure method of communication and you should not
send any personal health information via email.
If you have any questions about your rights as a research participant or the conduct of the study
you may contact: Dr. David Hill, Scientific Director, Lawson Health Research Institute at
519.667.6649. You will receive a copy of the fully signed informed consent document for your
records. You do not waive any legal rights by signing the consent.
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TITLE: Cerebrovascular and autonomic function outcomes in adolescents diagnosed with a
concussion
Principal Investigator: Dr. Kevin Shoemaker
Research Staff: Alexandra Harriss, Erin Moir & Arlene Fleischhauer
CONSENT
I have read the letter of information, have had the nature of the study explained to me and I agree
to participate. All questions have been answered to my satisfaction.
SIGNATURES
Signature of Participant

Date

Print

Signature of Person Obtaining Informed Consent

Date

Print
Do you consent to be contacted by the investigators for future research?
Signature:

NO

YES
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EDUCATION
The University of Western Ontario
MSc Kinesiology, Integrative Biosciences, 2017 (expected)
Thesis: Impaired dynamic cerebrovascular autoregulation in adolescent concussion
Advisor: Dr. J. Kevin Shoemaker, PhD
The University of Western Ontario
BA Honors Specialization in Kinesiology, 2013
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adolescent concussion. Abstract accepted. CASEM-AQMS Sports Medicine Conference,
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endorsement between acutely concussed adolescents and healthy, age-matched controls.
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Canada. June 7-10, 2017. Poster.
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Moir, M.E., et al. (2017). Impaired dynamic cerebral autoregulation to postural stress
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